

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>CD28null CD4 T-cell expansions in autoimmune... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-327/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-327" />
    
            <meta name="description" content="Read the original article in full on F1000Research: CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection" />
    
            <meta name="og:title" content="F1000Research Article: CD28&lt;sup&gt;null&lt;/sup&gt; CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection.">
            <meta name="og:description" content="Read the latest article version by Aalia Bano, Alejandra Pera, Ahmad Almoukayed, Thomas H.S. Clarke, Sukaina Kirmani, Kevin A. Davies, Florian Kern, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="18717">
            <meta name="article-id" content="17119">
            <meta name="dc.title" content="CD28&lt;sup&gt;null&lt;/sup&gt; CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection">
            <meta name="dc.description" content="Immunosenescence is thought to contribute to the increase of autoimmune diseases in older people. Immunosenescence is often associated with the presence of an expanded population of CD4 T cells lacking expression of CD28 (CD28 null ). These highly cytotoxic CD4 T cells were isolated from disease-affected tissues in patients with rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, or other chronic inflammatory diseases and their numbers appeared to be linked to disease severity. However, we recently demonstrated that the common herpes virus, cytomegalovirus (CMV), not ageing, is the major driver of this subset of cytotoxic T cells. In this review, we discuss how CMV might potentiate and exacerbate autoimmune disease through the expansion of CD28 null CD4 T cells.">
            <meta name="dc.subject" content="CD28 null, &#8203;&#8203;&#8203;&#8203;&#8203;&#8203;&#8203;CD4 T cell, autoimmune disease, cytomegalovirus infection">
            <meta name="dc.creator" content="Bano, Aalia">
            <meta name="dc.creator" content="Pera, Alejandra">
            <meta name="dc.creator" content="Almoukayed, Ahmad">
            <meta name="dc.creator" content="Clarke, Thomas H.S.">
            <meta name="dc.creator" content="Kirmani, Sukaina">
            <meta name="dc.creator" content="Davies, Kevin A.">
            <meta name="dc.creator" content="Kern, Florian">
            <meta name="dc.date" content="2019/03/25">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.17119.1">
            <meta name="dc.source" content="F1000Research 2019 8:327">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="CD28 null">
            <meta name="prism.keyword" content="&#8203;&#8203;&#8203;&#8203;&#8203;&#8203;&#8203;CD4 T cell">
            <meta name="prism.keyword" content="autoimmune disease">
            <meta name="prism.keyword" content="cytomegalovirus infection">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/03/25">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="327">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.17119.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-327">
            <meta name="citation_title" content="CD28&lt;sup&gt;null&lt;/sup&gt; CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection">
            <meta name="citation_abstract" content="Immunosenescence is thought to contribute to the increase of autoimmune diseases in older people. Immunosenescence is often associated with the presence of an expanded population of CD4 T cells lacking expression of CD28 (CD28 null ). These highly cytotoxic CD4 T cells were isolated from disease-affected tissues in patients with rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, or other chronic inflammatory diseases and their numbers appeared to be linked to disease severity. However, we recently demonstrated that the common herpes virus, cytomegalovirus (CMV), not ageing, is the major driver of this subset of cytotoxic T cells. In this review, we discuss how CMV might potentiate and exacerbate autoimmune disease through the expansion of CD28 null CD4 T cells.">
            <meta name="citation_description" content="Immunosenescence is thought to contribute to the increase of autoimmune diseases in older people. Immunosenescence is often associated with the presence of an expanded population of CD4 T cells lacking expression of CD28 (CD28 null ). These highly cytotoxic CD4 T cells were isolated from disease-affected tissues in patients with rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, or other chronic inflammatory diseases and their numbers appeared to be linked to disease severity. However, we recently demonstrated that the common herpes virus, cytomegalovirus (CMV), not ageing, is the major driver of this subset of cytotoxic T cells. In this review, we discuss how CMV might potentiate and exacerbate autoimmune disease through the expansion of CD28 null CD4 T cells.">
            <meta name="citation_keywords" content="CD28 null, &#8203;&#8203;&#8203;&#8203;&#8203;&#8203;&#8203;CD4 T cell, autoimmune disease, cytomegalovirus infection">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Aalia Bano">
            <meta name="citation_author_institution" content="Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK">
            <meta name="citation_author" content="Alejandra Pera">
            <meta name="citation_author_institution" content="Department of Immunology, Maimonides Institute for Biomedical Research (IMIBIC), Reina Sofia Hospital, University of Cordoba, Av. Menendez Pidal, 14004, Cordoba, Spain">
            <meta name="citation_author" content="Ahmad Almoukayed">
            <meta name="citation_author_institution" content="Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK">
            <meta name="citation_author" content="Thomas H.S. Clarke">
            <meta name="citation_author_institution" content="Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK">
            <meta name="citation_author" content="Sukaina Kirmani">
            <meta name="citation_author_institution" content="Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK">
            <meta name="citation_author" content="Kevin A. Davies">
            <meta name="citation_author_institution" content="Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK">
            <meta name="citation_author" content="Florian Kern">
            <meta name="citation_author_institution" content="Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK">
            <meta name="citation_publication_date" content="2019/03/25">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="327">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.17119.1">
            <meta name="citation_firstpage" content="327">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-327/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-327.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=18717 /> <input type=hidden id=articleId name=articleId value=17119 /> <input type=hidden id=xmlUrl value="/articles/8-327/v1/xml"/> <input type=hidden id=xmlFileName value="-8-327-v1.xml"> <input type=hidden id=article_uuid value=65ba3326-bf68-4786-8c48-63ba1b26f3f5 /> <input type=hidden id=referer value=""/> <input type="hidden" id="meta-article-title" value="CD28<sup>null</sup> CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection" /> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.17119.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.17119.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-327"
  },
  "headline": "CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection",
  "datePublished": "2019-03-25T09:19:08",
  "dateModified": "2019-03-25T09:19:08",
  "author": [
    {
      "@type": "Person",
      "name": "Aalia Bano"
    },    {
      "@type": "Person",
      "name": "Alejandra Pera"
    },    {
      "@type": "Person",
      "name": "Ahmad Almoukayed"
    },    {
      "@type": "Person",
      "name": "Thomas H.S. Clarke"
    },    {
      "@type": "Person",
      "name": "Sukaina Kirmani"
    },    {
      "@type": "Person",
      "name": "Kevin A. Davies"
    },    {
      "@type": "Person",
      "name": "Florian Kern"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Immunosenescence is thought to contribute to the increase of autoimmune diseases in older people. Immunosenescence is often associated with the presence of an expanded population of CD4 T cells lacking expression of CD28 (CD28null). These highly cytotoxic CD4 T cells were isolated from disease-affected tissues in patients with rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, or other chronic inflammatory diseases and their numbers appeared to be linked to disease severity. However, we recently demonstrated that the common herpes virus, cytomegalovirus (CMV), not ageing, is the major driver of this subset of cytotoxic T cells. In this review, we discuss how CMV might potentiate and exacerbate autoimmune disease through the expansion of CD28null CD4 T cells."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-327/v1",
            "name": "CD28null CD4 T-cell expansions in autoimmune disease suggest a link..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> CD28null CD4 T-cell expansions in autoimmune disease suggest a link... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=18717 data-id=17119 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17119.1" data-recommended="" data-doi="10.12688/f1000research.17119.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-327/v1/pdf?article_uuid=65ba3326-bf68-4786-8c48-63ba1b26f3f5" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-17119-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-17119-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-17119-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Bano A, Pera A, Almoukayed A <em>et al.</em> CD28<sup>null</sup> CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):327 (<a class=new-orange href="https://doi.org/10.12688/f1000research.17119.1" target=_blank>https://doi.org/10.12688/f1000research.17119.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-17119-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=17119 id=track-article-signin-17119 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17119?target=/articles/8-327/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18717 /> <input name=articleId type=hidden value=17119 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>CD28<sup>null</sup> CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:a.bano@bsms.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Aalia Bano</span></a><a href="https://orcid.org/0000-0003-4856-9530" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4856-9530</div><sup>1</sup>,&nbsp;</span><span class="">Alejandra Pera<sup>2</sup>,&nbsp;</span><span class="">Ahmad Almoukayed<sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Thomas H.S. Clarke<sup>1</sup>,&nbsp;</span><span class="">Sukaina Kirmani<sup>1</sup>,&nbsp;</span><span class="">Kevin A. Davies<sup>1</sup>,&nbsp;</span><span class="">Florian Kern<sup>1</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:a.bano@bsms.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Aalia Bano</span></a><a href="http://orcid.org/0000-0003-4856-9530" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4856-9530</div><sup>1</sup>,&nbsp;</span><span class="">Alejandra Pera<sup>2</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Ahmad Almoukayed<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Thomas H.S. Clarke<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Sukaina Kirmani<sup>1</sup>,&nbsp;</span><span class="">Kevin A. Davies<sup>1</sup>,&nbsp;</span><span class="">Florian Kern<sup>1</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 25 Mar 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.17119.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK<br/> <sup>2</sup> Department of Immunology, Maimonides Institute for Biomedical Research (IMIBIC), Reina Sofia Hospital, University of Cordoba, Av. Menendez Pidal, 14004, Cordoba, Spain<br/> <p> <div class=margin-bottom> Aalia Bano <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Alejandra Pera <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Ahmad Almoukayed <br/> <span>Roles: </span> Software </div> <div class=margin-bottom> Thomas H.S. Clarke <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Sukaina Kirmani <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Kevin A. Davies <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Florian Kern <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=48042-46005></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=48043-46006></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Immunosenescence is thought to contribute to the increase of autoimmune diseases in older people. Immunosenescence is often associated with the presence of an expanded population of CD4 T cells lacking expression of CD28 (CD28<sup>null</sup>). These highly cytotoxic CD4 T cells were isolated from disease-affected tissues in patients with rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, or other chronic inflammatory diseases and their numbers appeared to be linked to disease severity. However, we recently demonstrated that the common herpes virus, cytomegalovirus (CMV), not ageing, is the major driver of this subset of cytotoxic T cells. In this review, we discuss how CMV might potentiate and exacerbate autoimmune disease through the expansion of CD28<sup>null</sup> CD4 T cells. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> CD28 null, ​​​​​​​CD4 T cell, autoimmune disease, cytomegalovirus infection </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Aalia Bano (<a href="mailto:a.bano@bsms.ac.uk">a.bano@bsms.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Aalia Bano </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Bano A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Bano A, Pera A, Almoukayed A <em>et al.</em> CD28<sup>null</sup> CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):327 (<a href="https://doi.org/10.12688/f1000research.17119.1" target=_blank>https://doi.org/10.12688/f1000research.17119.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 25 Mar 2019, <b>8</b>(F1000 Faculty Rev):327 (<a href="https://doi.org/10.12688/f1000research.17119.1" target=_blank>https://doi.org/10.12688/f1000research.17119.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 25 Mar 2019, <b>8</b>(F1000 Faculty Rev):327 (<a href="https://doi.org/10.12688/f1000research.17119.1" target=_blank>https://doi.org/10.12688/f1000research.17119.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e234>Autoimmunity is not a rare phenomenon</h2><p class="" id=d12057e237>A degree of autoimmunity that is, reactivity of the immune system against our own tissues (‘self’) is found in everybody. This is because the immune system’s ability to discriminate ‘self’ and ‘non-self’ is not perfect. However, this imperfection usually is not enough to cause autoimmune disease. It appears that autoimmune disease requires “a genetic predisposition and environmental factors that trigger the immune pathways that lead, ultimately, to tissue destruction”<sup><a href="#ref-1">1</a></sup>. This review article was prompted by the recent (renewed) interest in CD28<sup>null</sup> CD4 T cell–driven tissue damage and focuses on the adaptive immune system. In the following sections, we explore some of these factors and a possible environmental trigger for some autoimmune diseases. Manifestations of autoimmunity may occur in almost any tissue. In someone who has a predisposition to autoimmune disease and is exposed to the respective trigger, the immune system, however, still has ways of regulating itself in order to prevent tissue damage. Some researchers would argue that autoimmune disease ultimately results from an imbalance between effector and regulatory immune responses (that is, between a damaging response and another one keeping it under control). This means that immune regulation may still prevent the occurrence of autoimmune disease even if an immune response against self is present. Disease occurs only if the mechanisms preventing tissue damage are no longer sufficient. This may happen, for example, if the regulatory response for some reason ceases to work or the damaging response is boosted.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e250>Predisposition to autoimmune disease</h2><p class="" id=d12057e253>There are many different factors facilitating the development of autoimmune disease. Among genetic defects, primary immunodeficiencies are often associated with autoimmunity and clinical manifestations thereof. Complement deficiencies, for example, have long been known to be risk factors for lupus<sup><a href="#ref-2">2</a></sup>. While infections often are considered the main consequences of primary immunodeficiencies, such defects may also interfere with immune regulation (for example, in preventing autoreactive T cells and B cells from being reined in by regulatory cells). An interesting example is a life-threatening autoimmune condition known as ‘IPEX syndrome’ (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). It is caused by mutations affecting the ‘master regulator’, forkhead box P3 (FOXP3) gene, an important transcription factor in regulatory T cells (Tregs)<sup><a href="#ref-3">3</a></sup>. As a result, there is loss of CD4 T-cell regulation, resulting in the production of autoantibodies and tissue destruction (the role of Tregs in peripheral tolerance is discussed below in the ‘Tolerance versus autoimmunity’ section). An example for an acquired predisposition to autoimmune diseases is HIV infection. The incidence of rheumatic autoimmune diseases observed in HIV infection (which is an acquired immunodeficiency) was relatively low during the era before highly active anti-retroviral therapy (HAART). However, following the introduction of HAART, a dramatic increase of conditions linked to an increase in CD4 T-cell counts was observed, which underscores the important role of CD4 T cells as effectors in such autoimmune diseases<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. A genetic predisposition, importantly, does not have to be a defect since many autoimmune diseases are associated with major histocompatibility complex (MHC) type. CD4 T cells recognise peptide antigens in the context of class II MHC molecules, and the mere presence of certain MHC alleles/allele groups may predispose an individual to autoimmune disease. One explanation for such associations is that MHC molecules allow specific, disease-associated peptides to be presented to CD4 T cells. Such a mechanism, for example, was discovered with respect to several HLA-DQB1 (‘DQ2’ and ‘DQ8’) alleles in gluten-sensitive enteropathy (‘coeliac disease’). The association in this case is so strong that the absence of DQ2 and DQ8 essentially rules out the disease<sup><a href="#ref-6">6</a></sup>. However, it is still only a minority of individuals with that tissue type who develop autoimmune disease.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e278>Tolerance versus autoimmunity</h2><p class="" id=d12057e281>Tolerance is a state where the immune system tolerates the presence of antigens that are recognised by immune cells without mounting an attack on the tissues displaying them. Whereas passive tolerance (essentially a gap in the immune receptor repertoire) is rare and refers to an absence of antigen recognition, active tolerance implies that mechanisms operate that actively down-regulate or suppress an otherwise detrimental mechanism. So-called central tolerance (or recessive tolerance) is achieved by eliminating all T lymphocytes that react with ‘self’ antigens during a rigorous selection process in the thymus. T cells bearing T-cell receptors (TCRs) that are autoreactive in the context of self-MHC molecules are deleted or may be diverted to become Tregs<sup><a href="#ref-7">7</a></sup>. However, ‘perfect’ central tolerance would require the presence of all relevant self-antigens in the thymus in sufficient quantity at the time of TCR selection. As this does not seem to be possible, some autoreactive cells tend to slip through the selection process<sup><a href="#ref-8">8</a></sup>. As a result, additional, ‘peripheral’ tolerance mechanisms are required to regulate inappropriate activation of autoreactive T cells in the periphery. Several different mechanisms contribute to peripheral tolerance.</p><p class="" id=d12057e292>The first important safeguard against the activation of autoreactive T cells is the requirement of two signals to induce T-cell activation. The interaction of TCRs with MHC/peptide complexes on antigen-presenting cells (APCs) (signal 1) alone is insufficient to cause T-cell activation. A second, co-stimulatory signal is required for full activation. This is usually provided by surface ligands called CD80 and CD86 on APCs. These interact with the co-stimulatory receptor, CD28, on T cells<sup><a href="#ref-9">9</a>–<a href="#ref-11">11</a></sup>. In the absence of the second signal, T cells become hypo-responsive and undergo apoptosis. A second safeguard is provided by the expression of the surface receptor molecule, cytotoxic T lymphocyte–associated protein 4 (CTLA-4), on activated T cells. Its affinity for CD80/CD86 is higher than that of CD28 and interaction between the former and CTLA-4 on effector T cells dampens down their activity. In addition, CTLA-4 may remove CD80/86 from APCs. There is strong evidence in the literature that regulating CD28-dependent T-cell activation is the most important role of CTLA-4<sup><a href="#ref-12">12</a></sup>. Tregs express CTLA-4 constitutively and its expression is further stabilised by FOXP3 expression, a ‘hallmark’ of Tregs. The effect of CTLA-4 ligation on Tregs seems to be an enhancement of suppressor activity. Whether or not the actual signalling through CTLA-4 has any role in this process remains controversial. However, suppressor activity of Tregs may keep the activation of cytotoxic T cells by self-antigens under control<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>.</p><p class="" id=d12057e313>In some situations, an environmental trigger can breach existing tolerance. This can occur by ‘unmasking’ epitopes that were not present during selection in the thymus. This is one of the postulated mechanisms by which enterovirus infection might trigger autoimmune diabetes<sup><a href="#ref-15">15</a></sup>. In this review, however, we focus on a different virus, cytomegalovirus (CMV), as a possible trigger of autoimmune disease. CMV is a common herpes virus. The precise mechanisms by which it might trigger autoimmunity have remained obscure but its association with autoimmune disease is striking<sup><a href="#ref-16">16</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e327>The nature of CD28<sup>null</sup> T cells</h2><p class="" id=d12057e333>The loss of CD28 associated with cellular senescence is persistent and must not be confused with the short-lived down-regulation of CD28 after T-cell activation, which usually reverses within 48 hours<sup><a href="#ref-17">17</a></sup>. Whereas non-antigen-experienced T cells express the co-stimulatory surface receptor, CD28, following the encounter of their cognate antigen, antigen-experienced T cells proliferate and differentiate along a pathway of increasing maturity that eventually leads to the loss of CD28, at least in CD8 T cells. Repeated cell division leads to telomere shortening down to a critical length below which cells are pushed into ‘replicative senescence’ and ultimately programmed cell death (apoptosis). Cells that have lost part or all of their ability to divide are considered senescent. CD28<sup>null</sup> T cells are ‘terminally differentiated’, have shortened telomeres and are often classified as senescent. They no longer require CD28 ligation for complete activation and at the same time have great cytotoxic potential (<a href="#T1">Table 1</a>). The loss of CD28 expression on both CD4 and CD8 T cells was long considered to be a consequence of normal (immune system) ageing, providing an explanation for accumulations of CD28<sup>null</sup> T cells in older people<sup><a href="#ref-18">18</a></sup>. For example, Effros <i>et al</i>. reported that significantly decreased populations of CD28<sup>+</sup> cells in centenarians compared with younger people and a loss of CD28<sup>+</sup> T cells in long-term culture appeared to indicate that loss of CD28 is a direct consequence of immunosenescence<sup><a href="#ref-19">19</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. CD28<sup>null</sup> CD4 T-cell associations with different clinical conditions.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d12057e381 class=n-a></a><thead><a name=d12057e383 class=n-a></a><tr><a name=d12057e385 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d12057e387 class=n-a></a>Disease</th><th align=left colspan=1 rowspan=1 valign=top><a name=d12057e390 class=n-a></a>Characteristics of CD4<sup>+</sup>28<sup>−</sup> T cells</th><th align=left colspan=1 rowspan=1 valign=top><a name=d12057e399 class=n-a></a>Invasion of<br class=br>disease-specific<br class=br>tissue</th><th align=left colspan=1 rowspan=1 valign=top><a name=d12057e406 class=n-a></a>Correlation to disease and therapies</th><th align=left colspan=1 rowspan=1 valign=top><a name=d12057e409 class=n-a></a>Possible self-antigens<br class=br>(residues) sharing sequences<br class=br>with cytomegalovirus (CMV)<br class=br>peptides</th><th align=left colspan=1 rowspan=1 valign=top><a name=d12057e419 class=n-a></a>References</th></tr></thead><tbody><a name=d12057e424 class=n-a></a><tr><a name=d12057e426 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d12057e428 class=n-a></a>Multiple<br class=br>sclerosis (MS)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e433 class=n-a></a>Pro-inflammatory (interferon-gamma [IFN-γ],<br class=br>tumour necrosis factor-alpha [TNF-α], and<br class=br>interleukin-2 [IL-2])<br class=br>IL-15 amplifies pathogenic properties in<br class=br>patients<br class=br>Fully potent regulatory T cells can suppress<br class=br>their pro-inflammatory features but not their<br class=br>expansion</td><td colspan=1 rowspan=1 valign=top><a name=d12057e451 class=n-a></a>Cerebrospinal fluid<br class=br>and brain lesions</td><td colspan=1 rowspan=1 valign=top><a name=d12057e456 class=n-a></a>Worse outcome in relapsing-remitting<br class=br>MS (RRMS)<br class=br>More frequent evoked potentials in<br class=br>RRMS<br class=br>Worse Expanded Disability Status<br class=br>Scale (EDSS) score</td><td colspan=1 rowspan=1 valign=top><a name=d12057e469 class=n-a></a>CMV major capsid protein UL86<br class=br>(981–1003) and MOG (34–56)<br class=br>Myelin basic peptide (93–105)<br class=br>and human herpesvirus-6 U24<br class=br>(1–13)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e481 class=n-a></a><a href="#ref-20">20</a>,<a href="#ref-29">29</a>,<a href="#ref-41">41</a>,<a href="#ref-42">42</a>,<a href="#ref-43">43</a>–<a href="#ref-47">47</a></td></tr><tr><a name=d12057e501 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d12057e503 class=n-a></a>Rheumatoid<br class=br>arthritis (RA)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e508 class=n-a></a>Proliferation mediated by fractalkine-<br class=br>expressing synoviocytes<br class=br>Dependent on chronic exposure from TNF-<br class=br>α/IL-15, resulting in limited T-cell receptor<br class=br>(TCR) diversity<br class=br>Pro-inflammatory (IFN-γ and TNF-α)<br class=br>In synovium, expresses chemokine<br class=br>receptors (CX<sub>3</sub>CR1)<br class=br>Activates natural killer cell receptors<br class=br>(CD11b, CD57, and NKG2D)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e533 class=n-a></a>Synovial fluid of<br class=br>affected joints<br class=br>Lung infiltration<br class=br>of CD4<sup>+</sup> in<br class=br>RA-associated<br class=br>pneumonitis</td><td colspan=1 rowspan=1 valign=top><a name=d12057e550 class=n-a></a>Preclinical atherosclerotic changes<br class=br>(endothelial dysfunction and carotid<br class=br>artery wall thickening)<br class=br>Disease severity positively correlates<br class=br>with amount of subset present<br class=br>Pre-disposition to extra-articular<br class=br>inflammatory lesions<br class=br>Infliximab reduces CD4<sup>+</sup>CD28<sup>−</sup> T cells</td><td colspan=1 rowspan=1 valign=top><a name=d12057e574 class=n-a></a>Human collagen Type II<br class=br>(associated with HLA-<br class=br>DRB1*0401 and HLA-<br class=br>DQA1*0301-DQB1*0302</td><td colspan=1 rowspan=1 valign=top><a name=d12057e584 class=n-a></a><a href="#ref-32">32</a>,<a href="#ref-48">48</a>,<a href="#ref-49">49</a>,<a href="#ref-50">50</a>,<a href="#ref-51">51</a>,<a href="#ref-52">52</a>–<a href="#ref-58">58</a></td></tr><tr><a name=d12057e608 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d12057e610 class=n-a></a>Graves’<br class=br>disease</td><td colspan=1 rowspan=1 valign=top><a name=d12057e615 class=n-a></a>Pro-inflammatory (IFN-γ)<br class=br>Mainly express CD45RO (activated/memory<br class=br>T cells)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e622 class=n-a></a>Eye muscle tissue,<br class=br>orbital fat tissue,<br class=br>and thyroid tissue</td><td colspan=1 rowspan=1 valign=top><a name=d12057e629 class=n-a></a>Severity of Graves’ disease<br class=br>Severity of goitre<br class=br>Serum FT3 and TRAb levels positively<br class=br>correlate<br class=br>Increased intracellular IFN-γ secretion<br class=br>in patients with Graves opthalmopathy<br class=br>Increased anti-thyrotropin receptor<br class=br>antibodies</td><td colspan=1 rowspan=1><a name=d12057e647 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d12057e650 class=n-a></a><a href="#ref-22">22</a>,<a href="#ref-59">59</a>,<a href="#ref-60">60</a></td></tr><tr><a name=d12057e661 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d12057e663 class=n-a></a>Systemic lupus<br class=br>erythematosus<br class=br>(SLE)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e670 class=n-a></a>Pro-inflammatory (IFN-γ)<br class=br>Increased percentage of CD4<sup>+</sup>NKG2D<sup>+</sup><br class=br>T cells Expression is induced by SLE<br class=br>monocytes</td><td colspan=1 rowspan=1 valign=top><a name=d12057e684 class=n-a></a>Skin lesions</td><td colspan=1 rowspan=1 valign=top><a name=d12057e687 class=n-a></a>Inversely correlates with regulatory T cells<br class=br>Disease severity (using both Systemic<br class=br>Lupus Erythematosus Disease Activity<br class=br>Index 2000 [SLEDAI-2K] and Systemic<br class=br>Lupus International Collaborating<br class=br>Clinics/American College of<br class=br>Rheumatology Damage Index [SDI])</td><td colspan=1 rowspan=1 valign=top><a name=d12057e703 class=n-a></a>CMV J1S = VASRPL F P<br class=br>PRSPGPS and HRES1 =<br class=br>PRHRHPQDPRSPGPA<br class=br>CMV protein gB and the<br class=br>autoantigen U1 70k<br class=br>C terminal half of HCMVpp65<br class=br>and anti-nuclear antibodies<br class=br>(BALB/C mice)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e722 class=n-a></a><a href="#ref-61">61</a>–<a href="#ref-66">66</a></td></tr><tr><a name=d12057e730 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d12057e732 class=n-a></a>Cardiovascular<br class=br>diseases</td><td colspan=1 rowspan=1 valign=top><a name=d12057e737 class=n-a></a>Expression of killer immunoglobulin-like<br class=br>receptors (KIRs) (that is, KIR2DS2)<br class=br>Destabilising fibrous caps of atherosclerotic<br class=br>plaques<br class=br>Release of perforin and granzyme B causes<br class=br>lysis of endothelial cells and vascular smooth<br class=br>muscle damage (without TCR stimulation)</td><td colspan=1 rowspan=1 valign=top><a name=d12057e753 class=n-a></a>Preferential<br class=br>invasion of<br class=br>unstable plaques</td><td colspan=1 rowspan=1 valign=top><a name=d12057e760 class=n-a></a>Severity of atherosclerosis and<br class=br>unstable angina (UA)<br class=br>Acute coronary events in patients with<br class=br>UA<br class=br>Reduced by statin therapy</td><td colspan=1 rowspan=1 valign=top><a name=d12057e771 class=n-a></a>hHSP60<sub>153–163</sub> with CMV<br class=br>UL122 and CMV US28</td><td colspan=1 rowspan=1 valign=top><a name=d12057e780 class=n-a></a><a href="#ref-57">57</a>,<a href="#ref-67">67</a>–<a href="#ref-69">69</a></td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e797>Immunosenescence, CD28<sup>null</sup> CD4 T cells, and autoimmunity</h2><p class="" id=d12057e803>Large populations of CD28<sup>null</sup> CD4 T cells were first identified in rheumatoid arthritis (RA) and later found in a wide variety of autoimmune diseases ranging from multiple sclerosis (MS) to Graves’ disease (GD)<sup><a href="#ref-20">20</a>–<a href="#ref-22">22</a></sup>. However, the loss of CD28 does not seem to indicate ‘anergy’. On the contrary, these cells acquire atypical cytotoxic properties resulting in a more rapid response. CD28<sup>null</sup> CD4 T cells have been described to have a memory effector phenotype and hence do not require a co-stimulatory input to be re-activated<sup><a href="#ref-23">23</a></sup>. They are also unusual in having a large cytoplasmic store of granzymes and perforins characteristic of CD8 T cells and natural killer (NK) cells<sup><a href="#ref-20">20</a></sup>. In addition, they produce large amounts of pro-inflammatory cytokines such as interferon-gamma (IFN-γ) and tumour necrosis factor (TNF), which potentially contribute to host tissue damage. Finally, CD28<sup>null</sup> CD4 T cells express NK cell markers such as NKG2D, which possibly further contribute to the amplification of the pro-inflammatory signals<sup><a href="#ref-24">24</a></sup>. These extra receptors also lower the threshold for the activation of CD28<sup>null</sup> CD4 T cells by specific and non-specific stimuli<sup><a href="#ref-25">25</a></sup>.</p><p class="" id=d12057e842>Interestingly, CD28<sup>null</sup> CD4 T cells are resistant to multiple forms of regulation. They are resistant to CD4<sup>+</sup>CD25<sup>+</sup>Treg-mediated suppression, a peripheral tolerance mechanism inhibiting proliferation and cytokine production. Tregs were shown to be unable to restrict the proliferation of CD28<sup>null</sup> CD4 T cells because of the lack of IL-2 receptor molecules (CD25) on these cells<sup><a href="#ref-26">26</a>–<a href="#ref-28">28</a></sup>. They are also resistant to apoptosis because of the down-regulation of the first apoptosis signal Fas receptor (Apo-1) and up-regulation of the B-cell lymphoma 2 (Bcl-2) apoptosis regulator. Both of these mechanisms contribute further to their accumulation<sup><a href="#ref-29">29</a></sup>. When CD28<sup>null</sup> T cells become activated, they rapidly express CTLA-4 and generate a pro-survival signal by reducing caspase-mediated apoptosis. Anti-apoptotic resistance is also rendered by B7.1 and B7.2/CTLA-4 interaction since blocking CTLA-4 increases Fas-FasL-dependent apoptosis<sup><a href="#ref-30">30</a></sup>. In light of these properties, expansions of CD28<sup>null</sup> CD4 T cells would be expected to be able to drive regulation-resistant tissue destruction.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e883>The ‘reversible’ nature of immunosenescence and CD28 loss</h2><p class="" id=d12057e886>According to Vallejo <i>et al</i>., persistent loss of CD28 most probably depends on repeated or continuous antigen contact<sup><a href="#ref-17">17</a></sup>. Since CD28 loss on T cells is frequently implicated in the development of immunosenescence, it is of interest that others have also observed that chronic, persistent antigen stimulation (as seen in chronic viral infection or chronic inflammatory/autoimmune disorders) accelerates immunological ageing<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>. CMV and HIV infections are prime examples of chronic virus infections associated with premature immune senescence<sup><a href="#ref-33">33</a>–<a href="#ref-36">36</a></sup> but hepatitis B virus also appears to be in that category<sup><a href="#ref-37">37</a></sup>. These observations raise the question as to whether cellular senescence might be reversible if the continuous antigenic stimulation were abrogated. And if so, might autoimmunity associated with CD28<sup>null</sup> CD4 T cells be reversible? Warrington <i>et al</i>., back in 2003, showed that CD28 loss on CD28<sup>null</sup> CD4 T cells can be reversed <i>in vitro</i> by stimulation with IL-12<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d12057e931>More recently, Akbar <i>et al</i>. reported that cellular senescence is an active process that is (at least partly) reversible<sup><a href="#ref-39">39</a></sup>. They showed that, apart from telomere erosion and DNA damage, a nutrient-sensing pathway is also responsible for activating p38 mitogen-activated protein (MAP) kinase in senescent cells. They also showed that small-molecule inhibitors of p38 reconstitute proliferation and telomerase activity following T-cell activation<sup><a href="#ref-39">39</a></sup>. Other studies showed that, in addition to these intrinsic pathways, T-cell senescence can be reversed extrinsically by cytokines secreted by APCs. A recent study in mice showed that p38 MAP kinase inhibition in APCs led to an increase in interleukin-12 (IL-12) production, which in turn enhanced T helper 1 (Th1) responses after vaccination in a mouse model<sup><a href="#ref-40">40</a></sup>. It is quite possible that in humans the effect of p38 MAP kinase inhibition on T cells<sup><a href="#ref-39">39</a></sup> is mediated by IL-12 as well.</p><p class="" id=d12057e953>The concept that cellular senescence is an active and reversible process is very confusing per se, since generally we associate the term ‘senescence’ with chronological age (which certainly is not reversible). Therefore, it is important to understand that senescent cells do not have to be ‘old’ in a chronological sense and may occur in young people. The fact that an increase in cells with an apparently ‘senescent’ phenotype is often associated with older age is explained by the accumulation of antigen-experienced cells in older people. Many of these will have been exposed to their cognate antigens for a long time and have gone through many rounds of proliferation. However, it is important to consider that fully functional, terminally differentiated effector cells would also be expected to produce aggressive cytokines (that is, have a secretory phenotype) without necessarily being senescent. The CD28<sup>null</sup> phenotype might include both senescent and fully functional effector cells. However, independently of these phenotypes, the age of an organism might have an effect on cellular function in general. Recent data suggest that, for example, naïve T cells in older people already show some signs of senescence<sup><a href="#ref-70">70</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e966>CD28<sup>null</sup> CD4 T cells are strongly associated with cytomegalovirus infection</h2><p class="" id=d12057e972>Because the prevalence of CMV infection increases with age, it was widely believed that CD28<sup>null</sup> T cells accumulate as a result of increasing age<sup><a href="#ref-71">71</a>–<a href="#ref-73">73</a></sup>. The most conspicuous accumulations of CD28<sup>null</sup> T cells occur in the CD8 compartment. These may be found in both young and older people and often constitute 20 to 80% of CD8 T cells. CD28<sup>null</sup> CD4 T-cell frequencies are generally one if not two orders of magnitude lower than those of CD28<sup>null</sup> CD8 T cells. Interestingly, their frequencies rarely exceed 1%, even in very old individuals, unless CMV infection is present. Our recent work indeed suggests that CMV infection is a major ‘trigger’ for the expansion of CD28<sup>null</sup> CD4 T cells, increasing frequencies more than 10-fold on average. (In CD8 T cells, the effect was a twofold increase.) However, the mechanisms by which this happens have remained unclear. Our work also shows that chronological age has a very small effect on CD28<sup>null</sup> CD4 T-cell expansions and only in CMV<sup>+</sup> individuals. Likewise, the effect of chronological age on the accumulation of CD28<sup>null</sup> CD8 T cells was found to be quite small. Expansions of these cells have long been associated with CMV infection, but the strength of the association between large numbers of these cells and CMV infection was grossly underestimated. Only in the presence of CMV infection do individuals exhibit cell numbers typically associated with clinical disease in the literature (usually several percent)<sup><a href="#ref-74">74</a></sup>. A recent publication reported that treatment with ganciclovir in CMV<sup>+</sup> patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis reduced the number of CD28<sup>null</sup> CD4 T cells<sup><a href="#ref-75">75</a></sup>. This finding seems to support both the ideas that these cells are driven by CMV infection and that their effects may be reversible when the offending antigen is removed<sup><a href="#ref-75">75</a></sup>.</p><p class="" id=d12057e1026>According to our results and those of others, many CD28<sup>null</sup> CD4 T cells are CMV-specific; however, it remains unclear whether other antigens are also recognised; no published report has ever convincingly shown the involvement of non-CMV antigens in triggering or driving CD28<sup>null</sup> CD4 T-cell expansions.</p><p class="" id=d12057e1035>Independently of any association with CMV, increased proportions of CD28<sup>null</sup> CD4 T cells have been implicated in a wide range of autoimmune diseases over more than two decades but also in atherosclerosis and coronary heart disease. These different ‘strands’ of research appear to have existed independently of each other<sup><a href="#ref-35">35</a></sup>. We recently reviewed the literature on these topics and found compelling evidence that CMV is in all probability a major driver of vascular complications in RA and other chronic inflammatory conditions<sup><a href="#ref-35">35</a>,<a href="#ref-76">76</a></sup>. However, in extension of that work, we now explore the role of CD28<sup>null</sup> CD4 T cells in autoimmune and chronic inflammatory diseases more generally. Our review brings together studies from different areas of autoimmunity all of which suggest a role for CD28<sup>null</sup> CD4 T cells in causing or exacerbating disease<sup><a href="#ref-77">77</a></sup>. The presence of large numbers of CD28<sup>null</sup> CD4 T cells in such conditions suggests a pathogenic role of this subset and indirectly one of CMV infection. Please note that most authors have reported increased proportions of these cells in various clinical situations rather than increased cell counts per unit of volume of blood (‘absolute counts’). Since lymphocytes may be redistributed between tissue and blood in different ways depending on a range of factors, absolute numbers per unit of blood are not necessarily more useful. In a recent publication, we were able to show that CMV-specific CD4 T cells drastically increase at older ages in both ‘absolute’ and relative terms; however, it also became clear that potentially relevant changes in subset proportions may be missed if the size of individual subsets is reported in ‘absolute’ counts<sup><a href="#ref-78">78</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e1073>Rheumatoid arthritis</h2><p class="" id=d12057e1076>RA is a systemic autoimmune disease and the condition in which CD28<sup>null</sup> CD4 T cells were first described and extensively studied<sup><a href="#ref-21">21</a>,<a href="#ref-48">48</a>,<a href="#ref-49">49</a>,<a href="#ref-79">79</a></sup>. A positive correlation between the presence of CD28<sup>null</sup> CD4 T cells and the extent of extra-articular manifestations suggested that these cells mediate some of the systemic effects of RA<sup><a href="#ref-48">48</a>,<a href="#ref-80">80</a></sup>. It is unclear in which compartment these cells are originally generated. However, up-regulation of the chemokine receptor CX3CR1 on CD28<sup>null</sup> CD4 T cells might allow them to reach the synovial fluid thanks to expression of the CX3CR1 ligand, fractalkine (CX3CL1), on synoviocytes<sup><a href="#ref-81">81</a></sup>. Remarkably, they are rarely found in the synovial membrane itself<sup><a href="#ref-82">82</a></sup>. Fractalkine and its receptor were previously proposed as promising candidates for anti-inflammatory interventions in RA but also cardiovascular disease and other chronic inflammatory conditions<sup><a href="#ref-83">83</a></sup>. In agreement with their role in systemic manifestations of RA, elevated levels of CD28<sup>null</sup> CD4 T cells were found, for example, in inflammatory pulmonary infiltrates where they express increased levels of the α4 integrin (alpha4/beta1, CD11b) and CD11a<sup><a href="#ref-20">20</a></sup>. Expression of these markers likewise is likely to facilitate tissue infiltration. The RA-associated HLA-DRB1*04 allele group was previously linked to an increase in CD28<sup>null</sup> CD4 T cells in both patients with RA and healthy controls<sup><a href="#ref-23">23</a></sup>. This might indicate that the presence of HLA-DRB1*04 alleles facilitates RA but also an increase in CD28<sup>null</sup> CD4 T cells. Carrying HLA-DRB1*04 in that sense represents a predisposition to autoimmunity; as such, autoimmunity could be mediated at least in part by CD28<sup>null</sup> CD4 T cells recognising a CMV epitope in this MHC context; however, to our knowledge, no CMV peptide presented by HLA-DRB1*04 has been reported to date. Our own work suggests that CMV infection is indeed the trigger for the expansions of these T cells.</p><p class="" id=d12057e1142>The antigen specificity of CD28<sup>null</sup> CD4 T cells is an area of great interest, but no antigens apart from CMV have been identified. Reactivity to CMV antigens was demonstrated in several studies, both in patients with RA and in healthy controls<sup><a href="#ref-20">20</a>,<a href="#ref-82">82</a>,<a href="#ref-84">84</a></sup>. Interestingly, both CMV DNA- and CMV-specific antibodies were reported in the synovial fluid of patients with RA<sup><a href="#ref-85">85</a></sup>.</p><p class="" id=d12057e1162>This suggests that CMV might have a direct role in CD28<sup>null</sup> CD4 T cell–mediated tissue damage in RA. Based on a number of publications, we have devised a hypothetical model how this might happen (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/18717/90dbf0d9-26f1-439f-b083-e8203cf57ea2_figure1.gif"><img alt="90dbf0d9-26f1-439f-b083-e8203cf57ea2_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/18717/90dbf0d9-26f1-439f-b083-e8203cf57ea2_figure1.gif"></a><div class=caption><h3>Figure 1. Potential link between CD28null T-cells, CMV, and Autoimmunity.</h3><p id=d12057e1181> <b>(1)</b> Endothelial cells (ECs) and synoviocytes can be infected by cytomegalovirus (CMV). <b>(2)</b> Synoviocytes may directly present CMV to CD28<sup>null</sup> CD4 T cells in the context of class II major histocompatibility complex (MHC). <b>(3)</b> Synoviocytes may alternatively release non-infectious exosomes (NIEs) containing the CMV antigens (as shown for ECs). Antigen-presenting cells (APCs) will take up the NIEs and process the antigens to be presented on class II MHC. <b>(4)</b> APCs present CMV antigens to CMV-specific CD28<sup>null</sup> CD4 T cells. <b>(5)</b> Activated CD28<sup>null</sup> CD4 T cells produce interferon-gamma (IFN-γ) and tumour necrosis factor (TNF). <b>(6)</b> This in turn will up-regulate the expression of CX3CL1 on synoviocytes and ECs. <b>(7)</b> CX3CR1-expressing CD28<sup>null</sup> CD4 T cells (and possibly regulatory T cells [Tregs]) travel from the lymph node to the inflamed joint (via the thoracic duct). <b>(8)</b> Interleukin-1 (IL-1) and TNF produced by activated macrophages cause tissue erosion and cartilage destruction. <b>(9)</b> Some CMV-specific CD28<sup>null</sup> CD4 T cells may cross-react with self-antigens. <b>(10)</b> Activated CD28<sup>null</sup> CD4 T cells evade suppression by Tregs and hence maintain an inflammatory state in the rheumatoid arthritis synovium.</p></div></div><p class="" id=d12057e1239>We hypothesise that CMV-infected synovial fibroblasts directly present CMV antigens to infiltrating T cells in a class II MHC context. It has been shown that synovial fibroblasts can activate CD28<sup>null</sup> CD4 T cells. However, the exact antigenic determinants remain unclear<sup><a href="#ref-50">50</a></sup>. Synovial fibroblasts might also present antigens indirectly via the release of non-infectious exosomes (NIEs) containing CMV antigens, as such a mechanism has been shown in endothelial cells (ECs). CMV-infected ECs release NIEs containing many CMV proteins. Following uptake of these NIEs by APCs, the CMV antigens are presented by MHC II on APCs to tissue-infiltrating CMV-specific CD4<sup>+</sup> T cells<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup>. Recognition of these antigens by the CD4 T cells would result in their activation and production of IFN-γ and TNF, both of which may up-regulate fractalkine expression on ECs and synoviocytes. This in turn would be likely to attract more CX3CR1-expressing CD28<sup>null</sup> CD4 T cells and Tregs to the inflamed synovium. In addition, CMV-specific CD28<sup>null</sup> CD4 T cells in the synovium might respond to autoantigens (as a result of cross-reactivity) and produce cytotoxic molecules like perforins and granzymes. CD28<sup>null</sup> CD4 T cells might also activate macrophages to release IL-1 or TNF or both, which could stimulate synovial fibroblasts to cause cartilage erosion by promoting connective tissue growth factor<sup><a href="#ref-88">88</a></sup>. This is only a working model and, though speculative, is supported by the cited observations.</p><p class="" id=d12057e1273>Apart from the adaptive immune response, macrophages and synovial fibroblasts might produce chemokines like IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and TNF in response to the presence of Toll-like receptor (TLR) ligands such as proteoglycans and, for example, bacterial DNA in the rheumatoid synovium<sup><a href="#ref-89">89</a></sup>. TLR-activated dendritic cells (DCs) migrate to the local lymph node to differentiate the primed autoreactive T cells towards different subtypes such as TH1 and TH2 (depending on the released cytokines)<sup><a href="#ref-90">90</a></sup>. A role of cytokines produced by macrophages and fibroblasts in autoimmune disease, in particular the role of TNF, has been well established. This is witnessed by the clinical success of anti-TNF therapies<sup><a href="#ref-91">91</a></sup>. Our model was conceived to illustrate one possible way how CMV infection might worsen the clinical course of RA via CD28<sup>null</sup> CD4 T cells. We are aware that there may be other ways to explain the effect of CMV in autoimmune disease and a discussion/exploration of all these possibilities is urgently needed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e1294>Multiple sclerosis</h2><p class="" id=d12057e1297>MS is a debilitating autoimmune disease characterised by demyelination and axonal loss<sup><a href="#ref-92">92</a></sup>. Myelin-specific T cells have been shown to be associated with the neuronal damage in patients with MS. In addition, genetic predisposition and other environmental factors have been identified as contributors. There is a strong association of MS with the HLA-DR15 and HLA DQ6 alleles. Among the environmental triggers, vitamin D deficiency and Epstein–Barr virus have long been associated with the disease<sup><a href="#ref-93">93</a></sup>. Both CD4<sup>+</sup> and CD8<sup>+</sup> T cells have been proposed to play a role in disease progression.</p><p class="" id=d12057e1314>Cytotoxic CD28<sup>null</sup> CD4 T cells are indeed found in increased proportions in patients with MS. They display up-regulated cell adhesion molecules, which probably allow them to infiltrate the brain and destroy oligodendrocytes<sup><a href="#ref-34">34</a>,<a href="#ref-41">41</a>,<a href="#ref-94">94</a>,<a href="#ref-95">95</a></sup>. Thewissen <i>et al</i>. reported that CD28<sup>null</sup> CD4 T-cell reactivity against myelin basic protein (MBP) in patients with MS was limited<sup><a href="#ref-20">20</a></sup>. However, in another study, cross-reactivity between a myelin peptide (MOG 35-55) and a CMV antigen UL-86 (981-1003) was observed in both rats and non-human primates<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d12057e1348>In a recent publication, CMV seropositivity of patients with MS was associated with higher percentages of CD28<sup>null</sup> CD4 T cells<sup><a href="#ref-34">34</a></sup>. Although no direct evidence of an association of CD28<sup>null</sup> CD4 T cells with MS severity was found in humans, the authors observed expansion of CD28<sup>null</sup> CD4 T cells in response to CMV infection in a mouse CMV (MCMV) model. There was a direct correlation between the frequencies of CD28<sup>null</sup> CD4 T cells and disease severity in a mouse model of MS, referred to as experimental autoimmune encephalitis (EAE)<sup><a href="#ref-34">34</a></sup>. Infection of EAE mice with MCMV further increased the frequencies of CD28<sup>null</sup> CD4 T cells. In these mouse models, CD28<sup>null</sup> CD4 T cells could also be induced by repeated stimulation of T cells with MBP or tetanus toxoid <i>in vitro</i>, indicating that the CD28<sup>null</sup> phenotype of CD4 T cells is not strictly antigen-dependent in these animals. Antigens other than CMV inducing this phenotype in humans, however, have not yet been identified. It is of note that CMV-specific CD8 T cells were previously reported in MS lesions<sup><a href="#ref-96">96</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e1391>Systemic lupus erythematosus</h2><p class="" id=d12057e1394>Systemic lupus erythematosus (SLE) affects multiple organs and is associated with increased mortality and morbidity. Most patients with SLE have sera positive for autoantibodies against La protein, which is a small ribonucleoprotein (RNP) associated with RNA polymerase. Interestingly, many viruses use La protein for their replication. A recent review on CMV infection in childhood-onset SLE describes CMV to either be the trigger of the disease or be responsible for a flare. This hypothesis is based on the association of La autoantibodies and latent CMV infection in many patients<sup><a href="#ref-97">97</a></sup>. Another study identified antibodies against the 47-kD La protein (SS-B) that recognised epitopes exhibiting sequence similarity with many herpes viruses, including CMV<sup><a href="#ref-98">98</a></sup>. Recently, the role of T cells in SLE has been recognised; T cells in SLE were shown to have a lower threshold for activation. Different mechanisms by which these T cells lower their activation threshold were discussed in a recent review by Mak and Kow<sup><a href="#ref-99">99</a></sup>. T cells in patients with SLE were shown to have decreased levels of CD3 ζ-chain (zeta chain) expression, measured by anti-CD3-ζ immunoblots, as compared with healthy controls. These so-called ‘lupus T cells’ were predominantly CD8<sup>+</sup> and CD16<sup>+</sup><sup><a href="#ref-100">100</a></sup>. Decreased levels of CD3 ζ-chain expression leads to a rewiring of the downstream ZaP-70 signalling pathway. This causes an increased calcium flux and greater activation of these T cells<sup><a href="#ref-99">99</a></sup>. Further work is required to characterise these T cells with regard to other co-stimulatory molecules, especially CD28, in the context of CMV infection. Also, it would be interesting to assess the potential cross-reactivity of CMV-reactive T cells with La protein.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e1426>Graves’ disease</h2><p class="" id=d12057e1429>GD is an autoimmune disease that affects the thyroid glands. Anti-thyrotropin-stimulating receptor antibodies were found to cause goitre and hyperthyroidism in these patients. A recent study found increased levels of CD28<sup>null</sup> CD4 T cells in GD patients compared with healthy controls. The same study found that the numbers of CD28<sup>null</sup> CD4 T cells correlated with the severity of the goitre and the ophthalmopathy. In patients with goitre-like symptoms, 15% of the total lymphocytes were CD28<sup>null</sup> CD4 T cells compared with only 6% in patients without goitre-like symptoms<sup><a href="#ref-22">22</a></sup>. Giving further support to a role of these T cells, the percentages of IFN-γ-producing CD28<sup>null</sup> CD4 T cells correlated with those of anti-thyrotropin-stimulating receptor autoantibodies (r = 0.4581, <i>P</i> = 0.002).</p><p class="" id=d12057e1452>IFN-γ-producing CD28<sup>null</sup> CD4 T cells were found not only in the circulation but also, in high numbers, in affected tissues such as the muscles in the eye and the thyroid<sup><a href="#ref-59">59</a>,<a href="#ref-101">101</a></sup>. High levels of circulating IFN-γ were observed in patients with GD and this might drive the destruction of thyroid tissue<sup><a href="#ref-22">22</a>,<a href="#ref-60">60</a></sup>.</p><p class="" id=d12057e1472>The role of virus infections in GD has been addressed in previous studies. For example, antibodies against the capsid antigens of Epstein–Barr virus were found at higher titers<sup><a href="#ref-102">102</a></sup>. However, the sera of these patients were not examined for anti-CMV antibodies. Since CMV is the driver of the CD28<sup>null</sup> CD4 T-cell population, a possible role for CMV in GD should be investigated.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e1486>Therapies targeting CD28<sup>null</sup> CD4 T cells</h2><p class="" id=d12057e1492>The consistent presence of potentially highly pathogenic CD28<sup>null</sup> CD4 T cells across different autoimmune diseases potentially makes them an interesting target for immunotherapy, and some immunotherapies that are currently in clinical use were shown to have effects on this subset, such as reducing its frequency or reversing its phenotype by causing re-expression of CD28. For example, anti-TNF-α therapy, which is widely used in the treatment of RA, was shown to limit the expansion and cytotoxic effects of CD28<sup>null</sup> CD4 T cells<sup><a href="#ref-32">32</a></sup>. Discontinuation of anti-TNF conversely may increase the risk of disease flares<sup><a href="#ref-103">103</a></sup>. Methotrexate leads to a reduction of CD28<sup>null</sup> CD4 T-cell levels, whereas infliximab induces the re-expression of CD28<sup><a href="#ref-51">51</a></sup>. Others have shown re-expression of CD28 by IL-12 stimulation<sup><a href="#ref-38">38</a></sup>. However, it remains unclear at this time what effect, for example, re-expression of CD28 might have.</p><p class="" id=d12057e1521>CD28<sup>null</sup> CD4 T cells are generally considered senescent cells as they have lost the ability to proliferate. Senescent cells usually have shortened telomeres, which activate the DNA damage repair (DDR) pathway. This pathway allows cells to be eliminated before they can pose a threat to the organism. (The mechanisms of senescence and exhaustion of T cells were reviewed in great detail in a recent review<sup><a href="#ref-104">104</a></sup>.) However, it appears that therapies aiming to reverse the senescence of CD28<sup>null</sup> CD4 T cells could be helpful for improving vaccination results. On the other hand, this might carry the risk of generating malignant cells. In addition, we believe it cannot be fully excluded that re-activating senescent CD28<sup>null</sup> CD4 T cells could worsen some of the conditions associated with their expansion. This could be the result of allowing even further proliferation of the then ‘reverted’ cells which now would be expressing CD28. (This is implying that in some situations senescent CD28<sup>null</sup> T cells could do less harm than their CD28<sup>+</sup> counterparts.)</p><p class="" id=d12057e1544>Therefore, therapies removing CD28<sup>null</sup> CD4 T cells might be a safer option and more beneficial. In theory, this could be achieved by targeting specific molecules on the CD28<sup>null</sup> CD4 T subset or by inducing apoptosis specifically of this subset. For example, apoptosis of CD28<sup>null</sup> CD4 T cells has been achieved by using the lipid-lowering rosuvastatin in patients with coronary heart disease<sup><a href="#ref-105">105</a></sup>. To reduce the tissue-infiltrating capacity of CD28<sup>null</sup> CD4 T cells, Broux <i>et al</i>. have suggested blocking CX3CR1 on these cells<sup><a href="#ref-41">41</a></sup>. It will be important for the success of any of these therapies to characterise CD28<sup>null</sup> CD4 T cells in more detail and to identify both their antigenic specificity and molecular markers. Additionally, antiviral therapies such as ganciclovir could potentially help to reduce the expansion of the CD28<sup>null</sup> CD4 T cells and hence possibly reduce the severity of many of the autoimmune diseases. However, the way in which such a strategy might be used clinically is, in reality, far from clear.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12057e1580>Conclusion and future perspective</h2><p class="" id=d12057e1583>CD28<sup>null</sup> CD4 T cells are an unusual population of chronically stimulated cells. In humans, they appear to accumulate in the presence of CMV infection. They are cytotoxic, produce large quantities of cytokines (a secretory phenotype associated with senescence) and display increased levels of adhesion markers, which suggests that they have access to diverse tissues. Their mere presence in autoimmune disease does not prove that they are actually involved in it or even cause it. However, reports indicating a correlation of their frequencies with severity suggest direct involvement in causing pathology. Studies in which these cells are specifically targeted might show to what extent they are involved in disease progression. Understanding the different antigenic specificities of these cells is a major challenge but will be helpful for developing specific immunotherapies. CMV is the clear trigger for the accumulation of these cells. However, we still do not know exactly which antigens (apart from CMV) these cells recognise. A better understanding of the antigen specificity of CD28<sup>null</sup> CD4 T cells would be a big step forward.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d12057e1 class=n-a></a><h2 class=main-title id=d12371>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d12057e1595 class=n-a></a><h2 class=main-title id=d12057e1597>Acknowledgements</h2><p class="" id=d12057e1600>We would like to thank Joyce Bowden for her contribution.</p></div><div class=back-section><a name=d12057e1604 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d12725>References</h2><div class="section ref-list"><a name=d12057e1604 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725675650"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e1611 class=n-a></a>Wang L, Wang FS, Gershwin ME: Human autoimmune diseases: a comprehensive update. <i>J Intern Med.</i> 2015; <b>278</b>(4): 369–95. <a target=xrefwindow id=d12057e1619 href="http://www.ncbi.nlm.nih.gov/pubmed/26212387">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1622 href="https://doi.org/10.1111/joim.12395">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725675650">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d12057e1635 class=n-a></a>Sullivan KE: Complement deficiency and autoimmunity. <i>Curr Opin Pediatr.</i> 1998; <b>10</b>(6): 600–6. <a target=xrefwindow id=d12057e1643 href="http://www.ncbi.nlm.nih.gov/pubmed/9848020">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1646 href="https://doi.org/10.1097/00008480-199810060-00011">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d12057e1655 class=n-a></a>Wildin RS, Ramsdell F, Peake J, <i> et al.</i>: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. <i>Nat Genet.</i> 2001; <b>27</b>(1): 18–20. <a target=xrefwindow id=d12057e1666 href="http://www.ncbi.nlm.nih.gov/pubmed/11137992">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1669 href="https://doi.org/10.1038/83707">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d12057e1678 class=n-a></a>Calabrese LH, Kirchner E, Shrestha R: Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. <i>Semin Arthritis Rheum.</i> 2005; <b>35</b>(3): 166–74. <a target=xrefwindow id=d12057e1686 href="http://www.ncbi.nlm.nih.gov/pubmed/16325657">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1689 href="https://doi.org/10.1016/j.semarthrit.2005.03.007">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730307162"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e1698 class=n-a></a>Yang JJ, Tsai MS, Sun HY, <i> et al.</i>: Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy. <i>J Microbiol Immunol Infect.</i> 2015; <b>48</b>(2): 130–6. <a target=xrefwindow id=d12057e1709 href="http://www.ncbi.nlm.nih.gov/pubmed/24064287">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1712 href="https://doi.org/10.1016/j.jmii.2013.08.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730307162">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d12057e1726 class=n-a></a>Kagnoff MF: Celiac disease: pathogenesis of a model immunogenetic disease. <i>J Clin Invest.</i> 2007; <b>117</b>(1): 41–9. <a target=xrefwindow id=d12057e1734 href="http://www.ncbi.nlm.nih.gov/pubmed/17200705">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1737 href="https://doi.org/10.1172/JCI30253">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1740 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1716218">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d12057e1749 class=n-a></a>Xing Y, Hogquist KA: T-cell tolerance: central and peripheral. <i>Cold Spring Harb Perspect Biol.</i> 2012; <b>4</b>(6): pii: a006957. <a target=xrefwindow id=d12057e1757 href="http://www.ncbi.nlm.nih.gov/pubmed/22661634">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1760 href="https://doi.org/10.1101/cshperspect.a006957">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1763 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3367546">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d12057e1772 class=n-a></a>von Boehmer H: Central tolerance: essential for preventing autoimmune disease? <i>Eur J Immunol.</i> 2009; <b>39</b>(9): 2313–6. <a target=xrefwindow id=d12057e1780 href="http://www.ncbi.nlm.nih.gov/pubmed/19714571">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1783 href="https://doi.org/10.1002/eji.200939575">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d12057e1792 class=n-a></a>Smith-Garvin JE, Koretzky GA, Jordan MS: T cell activation. <i>Annu Rev Immunol.</i> 2009; <b>27</b>: 591–619. <a target=xrefwindow id=d12057e1800 href="http://www.ncbi.nlm.nih.gov/pubmed/19132916">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1803 href="https://doi.org/10.1146/annurev.immunol.021908.132706">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1806 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2740335">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d12057e1815 class=n-a></a>Lafferty KJ, Cunningham AJ: A new analysis of allogeneic interactions. <i>Aust J Exp Biol Med Sci.</i> 1975; <b>53</b>(1): 27–42. <a target=xrefwindow id=d12057e1823 href="http://www.ncbi.nlm.nih.gov/pubmed/238498">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1826 href="https://doi.org/10.1038/icb.1975.3">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d12057e1835 class=n-a></a>Holtzman MJ, Green JM, Jayaraman S, <i> et al.</i>: Regulation of T cell apoptosis. <i>Apoptosis.</i> 2000; <b>5</b>(5): 459–71. <a target=xrefwindow id=d12057e1846 href="http://www.ncbi.nlm.nih.gov/pubmed/11256889">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1849 href="https://doi.org/10.1023/A:1009657321461">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d12057e1859 class=n-a></a>Walker LS: Treg and CTLA-4: two intertwining pathways to immune tolerance. <i>J Autoimmun.</i> 2013; <b>45</b>: 49–57. <a target=xrefwindow id=d12057e1867 href="http://www.ncbi.nlm.nih.gov/pubmed/23849743">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1870 href="https://doi.org/10.1016/j.jaut.2013.06.006">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1873 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3989116">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2766959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e1882 class=n-a></a>Jain N, Nguyen H, Chambers C, <i> et al.</i>: Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(4): 1524–8. <a target=xrefwindow id=d12057e1893 href="http://www.ncbi.nlm.nih.gov/pubmed/20080649">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1896 href="https://doi.org/10.1073/pnas.0910341107">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1900 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2824392">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2766959">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d12057e1913 class=n-a></a>Bour-Jordan H, Esensten JH, Martinez-Llordella M, <i> et al.</i>: Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. <i>Immunol Rev.</i> 2011; <b>241</b>(1): 180–205. <a target=xrefwindow id=d12057e1924 href="http://www.ncbi.nlm.nih.gov/pubmed/21488898">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1927 href="https://doi.org/10.1111/j.1600-065X.2011.01011.x">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3077803">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727191736"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e1940 class=n-a></a>Honkanen H, Oikarinen S, Nurminen N, <i> et al.</i>: Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. <i>Diabetologia.</i> 2017; <b>60</b>(3): 424–31. <a target=xrefwindow id=d12057e1951 href="http://www.ncbi.nlm.nih.gov/pubmed/28070615">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1954 href="https://doi.org/10.1007/s00125-016-4177-z">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727191736">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725586334"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e1967 class=n-a></a>Halenius A, Hengel H: Human cytomegalovirus and autoimmune disease. <i>Biomed Res Int.</i> 2014; <b>2014</b>: 472978. <a target=xrefwindow id=d12057e1975 href="http://www.ncbi.nlm.nih.gov/pubmed/24967373">PubMed Abstract </a> | <a target=xrefwindow id=d12057e1978 href="https://doi.org/10.1155/2014/472978">Publisher Full Text </a> | <a target=xrefwindow id=d12057e1981 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4022258">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725586334">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d12057e1994 class=n-a></a>Vallejo AN, Brandes JC, Weyand CM, <i> et al.</i>: Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. <i>J Immunol.</i> 1999; <b>162</b>(11): 6572–9. <a target=xrefwindow id=d12057e2005 href="http://www.ncbi.nlm.nih.gov/pubmed/10352273">PubMed Abstract </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d12057e2015 class=n-a></a>Weng NP, Akbar AN, Goronzy J: CD28<sup>-</sup> T cells: their role in the age-associated decline of immune function. <i>Trends Immunol.</i> 2009; <b>30</b>(7): 306–12. <a target=xrefwindow id=d12057e2026 href="http://www.ncbi.nlm.nih.gov/pubmed/19540809">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2029 href="https://doi.org/10.1016/j.it.2009.03.013">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2033 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2801888">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d12057e2042 class=n-a></a>Effros RB, Boucher N, Porter V, <i> et al.</i>: Decline in CD28<sup>+</sup> T cells in centenarians and in long-term T cell cultures: a possible cause for both <i>in vivo</i> and <i>in vitro</i> immunosenescence. <i>Exp Gerontol.</i> 1994; <b>29</b>(6): 601–9. <a target=xrefwindow id=d12057e2063 href="http://www.ncbi.nlm.nih.gov/pubmed/9435913">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2066 href="https://doi.org/10.1016/0531-5565(94)90073-6">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d12057e2075 class=n-a></a>Thewissen M, Somers V, Hellings N, <i> et al.</i>: CD4<sup>+</sup>CD28<sup>null</sup> T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. <i>J Immunol.</i> 2007; <b>179</b>(10): 6514–23. <a target=xrefwindow id=d12057e2093 href="http://www.ncbi.nlm.nih.gov/pubmed/17982040">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2096 href="https://doi.org/10.4049/jimmunol.179.10.6514">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d12057e2105 class=n-a></a>Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. <i>J Clin Invest.</i> 1996; <b>97</b>(9): 2027–37. <a target=xrefwindow id=d12057e2113 href="http://www.ncbi.nlm.nih.gov/pubmed/8621791">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2116 href="https://doi.org/10.1172/JCI118638">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2119 href="http://www.ncbi.nlm.nih.gov/pmc/articles/507276">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d12057e2128 class=n-a></a>Sun Z, Zhong W, Lu X, <i> et al.</i>: Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28<sup>-</sup> T cells. <i>J Clin Immunol.</i> 2008; <b>28</b>(5): 464–72. <a target=xrefwindow id=d12057e2142 href="http://www.ncbi.nlm.nih.gov/pubmed/18704663">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2146 href="https://doi.org/10.1007/s10875-008-9213-4">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d12057e2155 class=n-a></a>Thewissen M, Somers V, Venken K, <i> et al.</i>: Analyses of immunosenescent markers in patients with autoimmune disease. <i>Clin Immunol.</i> 2007; <b>123</b>(2): 209–18. <a target=xrefwindow id=d12057e2166 href="http://www.ncbi.nlm.nih.gov/pubmed/17317320">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2169 href="https://doi.org/10.1016/j.clim.2007.01.005">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d12057e2179 class=n-a></a>Warrington KJ, Takemura S, Goronzy JJ, <i> et al.</i>: CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. <i>Arthritis Rheum.</i> 2001; <b>44</b>(1): 13–20. <a target=xrefwindow id=d12057e2190 href="http://www.ncbi.nlm.nih.gov/pubmed/11212151">PubMed Abstract </a> | <a target="xrefwindow" id="d12057e2193" href="https://doi.org/10.1002/1529-0131(200101)44:1<13::AID-ANR3&gt;3.0.CO;2-6">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d12057e2202 class=n-a></a>Lindstrom TM, Robinson WH: Rheumatoid arthritis: a role for immunosenescence? <i>J Am Geriatr Soc.</i> 2010; <b>58</b>(8): 1565–75. <a target=xrefwindow id=d12057e2210 href="http://www.ncbi.nlm.nih.gov/pubmed/20942872">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2213 href="https://doi.org/10.1111/j.1532-5415.2010.02965.x">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2216 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3055796">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d12057e2225 class=n-a></a>Shevach EM: CD4<sup>+</sup> CD25<sup>+</sup> suppressor T cells: more questions than answers. <i>Nat Rev Immunol.</i> 2002; <b>2</b>(6): 389–400. <a target=xrefwindow id=d12057e2239 href="http://www.ncbi.nlm.nih.gov/pubmed/12093005">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2243 href="https://doi.org/10.1038/nri821">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718359868"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2252 class=n-a></a>Appay V, Zaunders JJ, Papagno L, <i> et al.</i>: Characterization of CD4<sup>+</sup> CTLs <i>ex vivo</i>. <i>J Immunol.</i> 2002; <b>168</b>(11): 5954–8. <a target=xrefwindow id=d12057e2270 href="http://www.ncbi.nlm.nih.gov/pubmed/12023402">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2273 href="https://doi.org/10.4049/jimmunol.168.11.5954 ">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718359868">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d12057e2286 class=n-a></a>Vallejo AN, Schirmer M, Weyand CM, <i> et al.</i>: Clonality and longevity of CD4<sup>+</sup>CD28<sup>null</sup> T cells are associated with defects in apoptotic pathways. <i>J Immunol.</i> 2000; <b>165</b>(11): 6301–7. <a target=xrefwindow id=d12057e2304 href="http://www.ncbi.nlm.nih.gov/pubmed/11086066">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2307 href="https://doi.org/10.4049/jimmunol.165.11.6301">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1001322"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2316 class=n-a></a>Markovic-Plese S, Cortese I, Wandinger KP, <i> et al.</i>: CD4<sup>+</sup>CD28<sup>-</sup> costimulation-independent T cells in multiple sclerosis. <i>J Clin Invest.</i> 2001; <b>108</b>(8): 1185–94. <a target=xrefwindow id=d12057e2334 href="http://www.ncbi.nlm.nih.gov/pubmed/11602626">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2337 href="https://doi.org/10.1172/JCI12516">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2340 href="http://www.ncbi.nlm.nih.gov/pmc/articles/209525">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1001322">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1159290"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2354 class=n-a></a>Hoff H, Knieke K, Cabail Z, <i> et al.</i>: Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28<sup>null</sup> T cells. <i>J Immunol.</i> 2009; <b>182</b>(9): 5342–51. <a target=xrefwindow id=d12057e2368 href="http://www.ncbi.nlm.nih.gov/pubmed/19380781">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2372 href="https://doi.org/10.4049/jimmunol.0801624">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1159290">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725659806"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2385 class=n-a></a>Dumitriu IE: The life (and death) of CD4<sup>+</sup> CD28<sup>null</sup> T cells in inflammatory diseases. <i>Immunology.</i> 2015; <b>146</b>(2): 185–93. <a target=xrefwindow id=d12057e2399 href="http://www.ncbi.nlm.nih.gov/pubmed/26190355">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2403 href="https://doi.org/10.1111/imm.12506">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2406 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4582960">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725659806">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d12057e2419 class=n-a></a>Lee GH, Lee WW: Unusual CD4<sup>+</sup>CD28<sup>-</sup> T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders. <i>Immune Netw.</i> 2016; <b>16</b>(6): 322–9. <a target=xrefwindow id=d12057e2433 href="http://www.ncbi.nlm.nih.gov/pubmed/28035207">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2437 href="https://doi.org/10.4110/in.2016.16.6.322">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2440 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5195841">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d12057e2449 class=n-a></a>Fernandez S, French MA, Price P: Immunosenescent CD57<sup>+</sup>CD4<sup>+</sup> T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART. <i>Dis Markers.</i> 2011; <b>31</b>(6): 337–42. <a target=xrefwindow id=d12057e2463 href="http://www.ncbi.nlm.nih.gov/pubmed/22182806">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2467 href="https://doi.org/10.3233/DMA-2011-0847">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2470 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3826487">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727486481"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2479 class=n-a></a>Vanheusden M, Broux B, Welten SPM, <i> et al.</i>: Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation. <i>Sci Rep.</i> 2017; <b>7</b>(1): 663. <a target=xrefwindow id=d12057e2490 href="http://www.ncbi.nlm.nih.gov/pubmed/28386103">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2493 href="https://doi.org/10.1038/s41598-017-00645-3">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2497 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5428769">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727486481">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d12057e2510 class=n-a></a>Broadley I, Pera A, Morrow G, <i> et al.</i>: Expansions of Cytotoxic CD4<sup>+</sup>CD28<sup>-</sup> T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection. <i>Front Immunol.</i> 2017; <b>8</b>: 195. <a target=xrefwindow id=d12057e2528 href="http://www.ncbi.nlm.nih.gov/pubmed/28303136">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2531 href="https://doi.org/10.3389/fimmu.2017.00195">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5332470">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727616241"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2544 class=n-a></a>Slot MC, Kroon AA, Damoiseaux JGMC, <i> et al.</i>: CD4<sup>+</sup>CD28<sup>null</sup> T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis. <i>Rheumatol Int.</i> 2017; <b>37</b>(5): 791–8. <a target=xrefwindow id=d12057e2562 href="http://www.ncbi.nlm.nih.gov/pubmed/28084533">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2565 href="https://doi.org/10.1007/s00296-016-3643-8">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2568 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5397454">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727616241">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d12057e2581 class=n-a></a>Wang Y, Bai J, Li F, <i> et al.</i>: Characteristics of expanded CD4<sup>+</sup>CD28<sup>null</sup> T cells in patients with chronic hepatitis B. <i>Immunol Invest.</i> 2009; <b>38</b>(5): 434–46. <a target=xrefwindow id=d12057e2599 href="http://www.ncbi.nlm.nih.gov/pubmed/19811419">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2602 href="https://doi.org/10.1080/08820130902943105">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d12057e2611 class=n-a></a>Warrington KJ, Vallejo AN, Weyand CM, <i> et al.</i>: CD28 loss in senescent CD4<sup>+</sup> T cells: Reversal by interleukin-12 stimulation. <i>Blood.</i> 2003; <b>101</b>(9): 3543–9. <a target=xrefwindow id=d12057e2625 href="http://www.ncbi.nlm.nih.gov/pubmed/12506015">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2629 href="https://doi.org/10.1182/blood-2002-08-2574">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726839617"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2638 class=n-a></a>Akbar AN, Henson SM, Lanna A: Senescence of T Lymphocytes: Implications for Enhancing Human Immunity. <i>Trends Immunol.</i> 2016; <b>37</b>(12): 866–76. <a target=xrefwindow id=d12057e2646 href="http://www.ncbi.nlm.nih.gov/pubmed/27720177">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2649 href="https://doi.org/10.1016/j.it.2016.09.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726839617">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d12057e2662 class=n-a></a>Yang Z, Zhang X, Darrah PA, <i> et al.</i>: The regulation of Th1 responses by the p38 MAPK. <i>J Immunol.</i> 2010; <b>185</b>(10): 6205–13. <a target=xrefwindow id=d12057e2673 href="http://www.ncbi.nlm.nih.gov/pubmed/20937847">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2676 href="https://doi.org/10.4049/jimmunol.1000243">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3050061">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d12057e2689 class=n-a></a>Broux B, Pannemans K, Zhang X, <i> et al.</i>: CX<sub>3</sub>CR1 drives cytotoxic CD4<sup>+</sup>CD28<sup>-</sup> T cells into the brain of multiple sclerosis patients. <i>J Autoimmun.</i> 2012; <b>38</b>(1): 10–9. <a target=xrefwindow id=d12057e2710 href="http://www.ncbi.nlm.nih.gov/pubmed/22123179">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2713 href="https://doi.org/10.1016/j.jaut.2011.11.006">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d12057e2723 class=n-a></a>Brok HP, Boven L, van Meurs M, <i> et al.</i>: The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys. <i>J Neuroimmunol.</i> 2007; <b>182</b>(1–2): 135–52. <a target=xrefwindow id=d12057e2734 href="http://www.ncbi.nlm.nih.gov/pubmed/17126916">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2737 href="https://doi.org/10.1016/j.jneuroim.2006.10.010">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d12057e2746 class=n-a></a>Miyazaki Y, Iwabuchi K, Kikuchi S, <i> et al.</i>: Expansion of CD4<sup>+</sup>CD28<sup>-</sup> T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis. <i>Mult Scler.</i> 2008; <b>14</b>(8): 1044–55. <a target=xrefwindow id=d12057e2764 href="http://www.ncbi.nlm.nih.gov/pubmed/18573819">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2767 href="https://doi.org/10.1177/1352458508092809">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725326317"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2776 class=n-a></a>Broux B, Mizee MR, Vanheusden M, <i> et al.</i>: IL-15 amplifies the pathogenic properties of CD4<sup>+</sup>CD28<sup>-</sup> T cells in multiple sclerosis. <i>J Immunol.</i> 2015; <b>194</b>(5): 2099–109. <a target=xrefwindow id=d12057e2794 href="http://www.ncbi.nlm.nih.gov/pubmed/25617471">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2797 href="https://doi.org/10.4049/jimmunol.1401547">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725326317">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731790216"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2810 class=n-a></a>Peeters LM, Vanheusden M, Somers V, <i> et al.</i>: Cytotoxic CD4<sup>+</sup> T Cells Drive Multiple Sclerosis Progression. <i>Front Immunol.</i> 2017; <b>8</b>: 1160. <a target=xrefwindow id=d12057e2824 href="http://www.ncbi.nlm.nih.gov/pubmed/28979263">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2828 href="https://doi.org/10.3389/fimmu.2017.01160">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2831 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5611397">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731790216">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718228624"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e2844 class=n-a></a>Zheng MM, Zhang XH: Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats. <i>Biochem Biophys Res Commun.</i> 2014; <b>443</b>(3): 1118–23. <a target=xrefwindow id=d12057e2852 href="http://www.ncbi.nlm.nih.gov/pubmed/24388990">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2855 href="https://doi.org/10.1016/j.bbrc.2013.12.122">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718228624">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d12057e2868 class=n-a></a>Tejada-Simon MV, Zang YC, Hong J, <i> et al.</i>: Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. <i>Ann Neurol.</i> 2003; <b>53</b>(2): 189–97. <a target=xrefwindow id=d12057e2879 href="http://www.ncbi.nlm.nih.gov/pubmed/12557285">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2882 href="https://doi.org/10.1002/ana.10425">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d12057e2892 class=n-a></a>Martens PB, Goronzy JJ, Schaid D, <i> et al.</i>: Expansion of unusual CD4<sup>+</sup> T cells in severe rheumatoid arthritis. <i>Arthritis Rheum.</i> 1997; <b>40</b>(6): 1106–14. <a target=xrefwindow id=d12057e2906 href="http://www.ncbi.nlm.nih.gov/pubmed/9182921">PubMed Abstract </a> | <a target="xrefwindow" id="d12057e2910" href="https://doi.org/10.1002/1529-0131(199706)40:6<1106::AID-ART14&gt;3.0.CO;2-#">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d12057e2919 class=n-a></a>Namekawa T, Wagner UG, Goronzy JJ, <i> et al.</i>: Functional subsets of CD4 T cells in rheumatoid synovitis. <i>Arthritis Rheum.</i> 1998; <b>41</b>(12): 2108–16. <a target=xrefwindow id=d12057e2930 href="http://www.ncbi.nlm.nih.gov/pubmed/9870867">PubMed Abstract </a> | <a target="xrefwindow" id="d12057e2933" href="https://doi.org/10.1002/1529-0131(199812)41:12<2108::AID-ART5&gt;3.0.CO;2-Q">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d12057e2942 class=n-a></a>Sawai H, Park YW, He X, <i> et al.</i>: Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. <i>Arthritis Rheum.</i> 2007; <b>56</b>(10): 3215–25. <a target=xrefwindow id=d12057e2953 href="http://www.ncbi.nlm.nih.gov/pubmed/17907166">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2956 href="https://doi.org/10.1002/art.22919">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d12057e2965 class=n-a></a>Maly K, Schirmer M: The story of CD4<sup>+</sup> CD28<sup>-</sup> T cells revisited: solved or still ongoing? <i>J Immunol Res.</i> 2015; <b>2015</b>: 348746. <a target=xrefwindow id=d12057e2979 href="http://www.ncbi.nlm.nih.gov/pubmed/25834833">PubMed Abstract </a> | <a target=xrefwindow id=d12057e2983 href="https://doi.org/10.1155/2015/348746">Publisher Full Text </a> | <a target=xrefwindow id=d12057e2986 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4365319">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d12057e2995 class=n-a></a>Sawai H, Park YW, Roberson J, <i> et al.</i>: T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. <i>Arthritis Rheum.</i> 2005; <b>52</b>(5): 1392–401. <a target=xrefwindow id=d12057e3006 href="http://www.ncbi.nlm.nih.gov/pubmed/15880821">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3009 href="https://doi.org/10.1002/art.21140">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d12057e3018 class=n-a></a>Fasth AER, Björkström NK, Anthoni M, <i> et al.</i>: Activating NK-cell receptors co-stimulate CD4<sup>+</sup>CD28<sup>-</sup> T cells in patients with rheumatoid arthritis. <i>Eur J Immunol.</i> 2010; <b>40</b>(2): 378–87. <a target=xrefwindow id=d12057e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/19904767">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3039 href="https://doi.org/10.1002/eji.200939399">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d12057e3049 class=n-a></a>Berg L, Rönnelid J, Sanjeevi CB, <i> et al.</i>: Interferon-gamma production in response to <i>in vitro</i> stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1*0401 and HLA-DQ8. <i>Arthritis Res.</i> 2000; <b>2</b>(1): 75–84. <a target=xrefwindow id=d12057e3063 href="http://www.ncbi.nlm.nih.gov/pubmed/11219392">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3067 href="https://doi.org/10.1186/ar71">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3070 href="http://www.ncbi.nlm.nih.gov/pmc/articles/17806">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d12057e3079 class=n-a></a>Zhang X, Nakajima T, Goronzy JJ, <i> et al.</i>: Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis. <i>Arthritis Rheum.</i> 2005; <b>52</b>(12): 3839–49. <a target=xrefwindow id=d12057e3090 href="http://www.ncbi.nlm.nih.gov/pubmed/16329093">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3093 href="https://doi.org/10.1002/art.21482">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d12057e3102 class=n-a></a>Turesson C, Matteson EL, Colby TV, <i> et al.</i>: Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. <i>Arthritis Rheum.</i> 2005; <b>52</b>(1): 73–9. <a target=xrefwindow id=d12057e3113 href="http://www.ncbi.nlm.nih.gov/pubmed/15641082">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3116 href="https://doi.org/10.1002/art.20765">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d12057e3125 class=n-a></a>Gerli R, Schillaci G, Giordano A, <i> et al.</i>: CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. <i>Circulation.</i> 2004; <b>109</b>(22): 2744–8. <a target=xrefwindow id=d12057e3136 href="http://www.ncbi.nlm.nih.gov/pubmed/15159291">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3139 href="https://doi.org/10.1161/01.CIR.0000131450.66017.B3">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d12057e3148 class=n-a></a>Pawlik A, Ostanek L, Brzosko I, <i> et al.</i>: Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis. <i>Rheumatol Int.</i> 2004; <b>24</b>(6): 351–4. <a target=xrefwindow id=d12057e3159 href="http://www.ncbi.nlm.nih.gov/pubmed/14504910">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3162 href="https://doi.org/10.1007/s00296-003-0374-4">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d12057e3171 class=n-a></a>Hiromatsu Y, Yang D, Bednarczuk T, <i> et al.</i>: Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. <i>J Clin Endocrinol Metab.</i> 2000; <b>85</b>(3): 1194–9. <a target=xrefwindow id=d12057e3182 href="http://www.ncbi.nlm.nih.gov/pubmed/10720061">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3185 href="https://doi.org/10.1210/jcem.85.3.6433">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728269292"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3195 class=n-a></a>Wang F, Chen L, Shen Q, <i> et al.</i>: Characterization and clinical relevance of circulating CD4<sup>+</sup>CD28<sup>-</sup> T cells in Graves' disease. <i>Immunol Lett.</i> 2015; <b>165</b>(1): 47–51. <a target=xrefwindow id=d12057e3213 href="http://www.ncbi.nlm.nih.gov/pubmed/25839128">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3216 href="https://doi.org/10.1016/j.imlet.2015.03.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728269292">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d12057e3229 class=n-a></a>Yang D, Wang H, Ni B, <i> et al.</i>: Mutual activation of CD4<sup>+</sup> T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus. <i>Mol Immunol.</i> 2009; <b>46</b>(7): 1432–42. <a target=xrefwindow id=d12057e3243 href="http://www.ncbi.nlm.nih.gov/pubmed/19200602">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3247 href="https://doi.org/10.1016/j.molimm.2008.12.010">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d12057e3256 class=n-a></a>Kita Y, Kuroda K, Mimori T, <i> et al.</i>: T cell receptor clonotypes in skin lesions from patients with systemic lupus erythematosus. <i>J Invest Dermatol.</i> 1998; <b>110</b>(1): 41–6. <a target=xrefwindow id=d12057e3267 href="http://www.ncbi.nlm.nih.gov/pubmed/9424085">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3270 href="https://doi.org/10.1046/j.1523-1747.1998.00072.x">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732386394"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3279 class=n-a></a>Piantoni S, Regola F, Zanola A, <i> et al.</i>: Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes. <i>Lupus.</i> 2018; <b>27</b>(1): 143–9. <a target=xrefwindow id=d12057e3290 href="http://www.ncbi.nlm.nih.gov/pubmed/28764616">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3293 href="https://doi.org/10.1177/0961203317722848">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732386394">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725799762"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3306 class=n-a></a>Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cárdenas RV, <i> et al.</i>: Circulating CD4<sup>+</sup>CD28null and extra-thymic CD4<sup>+</sup>CD8<sup>+</sup> double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients. <i>Lupus.</i> 2016; <b>25</b>(3): 233–40. <a target=xrefwindow id=d12057e3327 href="http://www.ncbi.nlm.nih.gov/pubmed/26385221">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3330 href="https://doi.org/10.1177/0961203315604910">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725799762">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d12057e3343 class=n-a></a>Francis L, Perl A: Infection in systemic lupus erythematosus: friend or foe? <i>Int J Clin Rheumtol.</i> 2010; <b>5</b>(1): 59–74. <a target=xrefwindow id=d12057e3351 href="http://www.ncbi.nlm.nih.gov/pubmed/20209114">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3354 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2830655">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d12057e3364 class=n-a></a>Hsieh AH, Jhou YJ, Liang CT, <i> et al.</i>: Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice. <i>Arthritis Res Ther.</i> 2011; <b>13</b>(5): R162. <a target=xrefwindow id=d12057e3375 href="http://www.ncbi.nlm.nih.gov/pubmed/21989080">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3378 href="https://doi.org/10.1186/ar3481">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3382 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3308095">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d12057e3391 class=n-a></a>Bason C, Corrocher R, Lunardi C, <i> et al.</i>: Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. <i>Lancet.</i> 2003; <b>362</b>(9400): 1971–7. <a target=xrefwindow id=d12057e3402 href="http://www.ncbi.nlm.nih.gov/pubmed/14683657">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3405 href="https://doi.org/10.1016/S0140-6736(03)15016-7">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d12057e3414 class=n-a></a>Brugaletta S, Biasucci LM, Pinnelli M, <i> et al.</i>: Novel anti-inflammatory effect of statins: reduction of CD4<sup>+</sup>CD28null T lymphocyte frequency in patients with unstable angina. <i>Heart.</i> 2006; <b>92</b>(2): 249–50. <a target=xrefwindow id=d12057e3428 href="http://www.ncbi.nlm.nih.gov/pubmed/16415193">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3432 href="https://doi.org/10.1136/hrt.2004.052282">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3435 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1860749">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d12057e3444 class=n-a></a>Zal B, Kaski JC, Arno G, <i> et al.</i>: Heat-shock protein 60-reactive CD4<sup>+</sup>CD28<sup>null</sup> T cells in patients with acute coronary syndromes. <i>Circulation.</i> 2004; <b>109</b>(10): 1230–5. <a target=xrefwindow id=d12057e3462 href="http://www.ncbi.nlm.nih.gov/pubmed/14993140">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3465 href="https://doi.org/10.1161/01.CIR.0000118476.29352.2A">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725441630"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3474 class=n-a></a>Goronzy JJ, Fang F, Cavanagh MM, <i> et al.</i>: Naive T cell maintenance and function in human aging. <i>J Immunol.</i> 2015; <b>194</b>(9): 4073–80. <a target=xrefwindow id=d12057e3485 href="http://www.ncbi.nlm.nih.gov/pubmed/25888703">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3488 href="https://doi.org/10.4049/jimmunol.1500046">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3492 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4452284">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725441630">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d12057e3505 class=n-a></a>Weinberger B, Lazuardi L, Weiskirchner I, <i> et al.</i>: Healthy aging and latent infection with CMV lead to distinct changes in CD8<sup>+</sup> and CD4<sup>+</sup> T-cell subsets in the elderly. <i>Hum Immunol.</i> 2007; <b>68</b>(2): 86–90. <a target=xrefwindow id=d12057e3523 href="http://www.ncbi.nlm.nih.gov/pubmed/17321897">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3526 href="https://doi.org/10.1016/j.humimm.2006.10.019">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726152661"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3536 class=n-a></a>Weltevrede M, Eilers R, de Melker HE, <i> et al.</i>: Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review. <i>Exp Gerontol.</i> 2016; <b>77</b>: 87–95. <a target=xrefwindow id=d12057e3547 href="http://www.ncbi.nlm.nih.gov/pubmed/26883338">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3550 href="https://doi.org/10.1016/j.exger.2016.02.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726152661">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d12057e3563 class=n-a></a>Olsson J, Wikby A, Johansson B, <i> et al.</i>: Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. <i>Mech Ageing Dev.</i> 2000; <b>121</b>(1–3): 187–201. <a target=xrefwindow id=d12057e3574 href="http://www.ncbi.nlm.nih.gov/pubmed/11164473">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3577 href="https://doi.org/10.1016/S0047-6374(00)00210-4">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d12057e3586 class=n-a></a>Pera A, Caserta S, Albanese F, <i> et al.</i>: CD28<sup>null</sup> pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death. <i>Theranostics.</i> 2018; <b>8</b>(16): 4509–19. <a target=xrefwindow id=d12057e3600 href="http://www.ncbi.nlm.nih.gov/pubmed/30214635">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3604 href="https://doi.org/10.7150/thno.27428">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3607 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6134924">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733808571"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3616 class=n-a></a>Chanouzas D, Sagmeister M, Faustini S, <i> et al.</i>: Subclinical Reactivation of Cytomegalovirus Drives CD4<sup>+</sup>CD28<sup>null</sup> T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. <i>J Infect Dis.</i> 2019; <b>219</b>(2): 234–44. <a target=xrefwindow id=d12057e3634 href="http://www.ncbi.nlm.nih.gov/pubmed/30102389">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3637 href="https://doi.org/10.1093/infdis/jiy493">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3640 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6306020">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733808571">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d12057e3653 class=n-a></a>Pera A, Broadley I, Davies KA, <i> et al.</i>: Cytomegalovirus as a Driver of Excess Cardiovascular Mortality in Rheumatoid Arthritis: A Red Herring or a Smoking Gun? <i>Circ Res.</i> 2017; <b>120</b>(2): 274–7. <a target=xrefwindow id=d12057e3664 href="http://www.ncbi.nlm.nih.gov/pubmed/28104768">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3667 href="https://doi.org/10.1161/CIRCRESAHA.116.309982">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d12057e3676 class=n-a></a>Thewissen M, Linsen L, Somers V, <i> et al.</i>: Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. <i>Ann N Y Acad Sci.</i> 2005; <b>1051</b>: 255–62. <a target=xrefwindow id=d12057e3687 href="http://www.ncbi.nlm.nih.gov/pubmed/16126966">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3690 href="https://doi.org/10.1196/annals.1361.066">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d12057e3700 class=n-a></a>Bajwa M, Vita S, Vescovini R, <i> et al.</i>: CMV-Specific T-cell Responses at Older Ages: Broad Responses With a Large Central Memory Component May Be Key to Long-term Survival. <i>J Infect Dis.</i> 2017; <b>215</b>(18): 1212–20. <a target=xrefwindow id=d12057e3711 href="http://www.ncbi.nlm.nih.gov/pubmed/28199648">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3714 href="https://doi.org/10.1093/infdis/jix080">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5854018">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d12057e3727 class=n-a></a>Fasth AER, Cao D, van Vollenhoven R, <i> et al.</i>: CD28<sup>null</sup>CD4<sup>+</sup> T cells--characterization of an effector memory T-cell population in patients with rheumatoid arthritis. <i>Scand J Immunol.</i> 2004; <b>60</b>(1–2): 199–208. <a target=xrefwindow id=d12057e3745 href="http://www.ncbi.nlm.nih.gov/pubmed/15238090">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3748 href="https://doi.org/10.1111/j.0300-9475.2004.01464.x">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d12057e3757 class=n-a></a>Pawlik A, Ostanek L, Brzosko I, <i> et al.</i>: The expansion of CD4<sup>+</sup>CD28<sup>-</sup> T cells in patients with rheumatoid arthritis. <i>Arthritis Res Ther.</i> 2003; <b>5</b>(4): R210–3. <a target=xrefwindow id=d12057e3775 href="http://www.ncbi.nlm.nih.gov/pubmed/12823856">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3778 href="https://doi.org/10.1186/ar766">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3781 href="http://www.ncbi.nlm.nih.gov/pmc/articles/165060">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d12057e3790 class=n-a></a>Goronzy JJ, Henel G, Sawai H, <i> et al.</i>: Costimulatory pathways in rheumatoid synovitis and T-cell senescence. <i>Ann N Y Acad Sci.</i> 2005; <b>1062</b>: 182–94. <a target=xrefwindow id=d12057e3801 href="http://www.ncbi.nlm.nih.gov/pubmed/16461801">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3804 href="https://doi.org/10.1196/annals.1358.022">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d12057e3813 class=n-a></a>Fasth AE, Snir O, Johansson AA, <i> et al.</i>: Skewed distribution of proinflammatory CD4<sup>+</sup>CD28<sup>nu</sup>ll T cells in rheumatoid arthritis. <i>Arthritis Res Ther.</i> 2007; <b>9</b>(5): R87. <a target=xrefwindow id=d12057e3831 href="http://www.ncbi.nlm.nih.gov/pubmed/17825098">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3834 href="https://doi.org/10.1186/ar2286">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3837 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2212553">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d12057e3846 class=n-a></a>Jones B, Koch AE, Ahmed S: Pathological role of fractalkine/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions. <i>Front Immunol.</i> 2011; <b>2</b>: 82. <a target=xrefwindow id=d12057e3854 href="http://www.ncbi.nlm.nih.gov/pubmed/22566871">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3857 href="https://doi.org/10.3389/fimmu.2011.00082">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3860 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3341950">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718359874"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e3870 class=n-a></a>van Leeuwen EM, Remmerswaal EB, Vossen MT, <i> et al.</i>: Emergence of a CD4<sup>+</sup>CD28<sup>-</sup> granzyme B<sup>+</sup>, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. <i>J Immunol.</i> 2004; <b>173</b>(3): 1834–41. <a target=xrefwindow id=d12057e3891 href="http://www.ncbi.nlm.nih.gov/pubmed/15265915">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3894 href="https://doi.org/10.4049/jimmunol.173.3.1834">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718359874">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d12057e3907 class=n-a></a>Einsele H, Steidle M, Müller CA, <i> et al.</i>: Demonstration of cytomegalovirus (CMV) DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis. <i>J Rheumatol.</i> 1992; <b>19</b>(5): 677–81. <a target=xrefwindow id=d12057e3918 href="http://www.ncbi.nlm.nih.gov/pubmed/1319485">PubMed Abstract </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d12057e3927 class=n-a></a>Mehraein Y, Lennerz C, Ehlhardt S, <i> et al.</i>: Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-<i>in situ</i> hybridization. <i>Mod Pathol.</i> 2004; <b>17</b>(7): 781–9. <a target=xrefwindow id=d12057e3941 href="http://www.ncbi.nlm.nih.gov/pubmed/15044921">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3945 href="https://doi.org/10.1038/modpathol.3800119">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d12057e3954 class=n-a></a>Walker JD, Maier CL, Pober JS: Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4<sup>+</sup> memory T cells by releasing antigenic exosomes. <i>J Immunol.</i> 2009; <b>182</b>(3): 1548–59. <a target=xrefwindow id=d12057e3965 href="http://www.ncbi.nlm.nih.gov/pubmed/19155503">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3968 href="https://doi.org/10.4049/jimmunol.182.3.1548 ">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3972 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2630120">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d12057e3981 class=n-a></a>Nozawa K, Fujishiro M, Takasaki Y, <i> et al.</i>: Inhibition of rheumatoid arthritis by blocking connective tissue growth factor. <i>World J Orthop.</i> 2014; <b>5</b>(5): 653–9. <a target=xrefwindow id=d12057e3992 href="http://www.ncbi.nlm.nih.gov/pubmed/25405094">PubMed Abstract </a> | <a target=xrefwindow id=d12057e3995 href="https://doi.org/10.5312/wjo.v5.i5.653">Publisher Full Text </a> | <a target=xrefwindow id=d12057e3999 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4133473">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d12057e4008 class=n-a></a>van der Heijden IM, Wilbrink B, Tchetverikov I, <i> et al.</i>: Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. <i>Arthritis Rheum.</i> 2000; <b>43</b>(3): 593–8. <a target=xrefwindow id=d12057e4019 href="http://www.ncbi.nlm.nih.gov/pubmed/10728753">PubMed Abstract </a> | <a target="xrefwindow" id="d12057e4022" href="https://doi.org/10.1002/1529-0131(200003)43:3<593::AID-ANR16&gt;3.0.CO;2-1">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d12057e4032 class=n-a></a>Sallusto F, Lanzavecchia A: Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. <i>Immunol Rev.</i> 2000; <b>177</b>: 134–40. <a target=xrefwindow id=d12057e4040 href="http://www.ncbi.nlm.nih.gov/pubmed/11138771">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4043 href="https://doi.org/10.1034/j.1600-065X.2000.17717.x">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718325307"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e4052 class=n-a></a>Lipsky PE, van der Heijde DM, St Clair EW, <i> et al.</i>: Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. <i>N Engl J Med.</i> 2000; <b>343</b>(22): 1594–602. <a target=xrefwindow id=d12057e4063 href="http://www.ncbi.nlm.nih.gov/pubmed/11096166">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4066 href="https://doi.org/10.1056/NEJM200011303432202">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718325307">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d12057e4079 class=n-a></a>Ransohoff RM, Hafler DA, Lucchinetti CF: Multiple sclerosis-a quiet revolution. <i>Nat Rev Neurol.</i> 2015; <b>11</b>(3): 134–42. <a target=xrefwindow id=d12057e4087 href="http://www.ncbi.nlm.nih.gov/pubmed/25686758">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4090 href="https://doi.org/10.1038/nrneurol.2015.14">Publisher Full Text </a> | <a target=xrefwindow id=d12057e4093 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4556342">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d12057e4102 class=n-a></a>Olsson T, Barcellos LF, Alfredsson L: Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. <i>Nat Rev Neurol.</i> 2017; <b>13</b>(1): 25–36. <a target=xrefwindow id=d12057e4110 href="http://www.ncbi.nlm.nih.gov/pubmed/27934854">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4113 href="https://doi.org/10.1038/nrneurol.2016.187">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d12057e4122 class=n-a></a>Zaguia F, Saikali P, Ludwin S, <i> et al.</i>: Cytotoxic NKG2C<sup>+</sup> CD4 T cells target oligodendrocytes in multiple sclerosis. <i>J Immunol.</i> 2013; <b>190</b>(6): 2510–8. <a target=xrefwindow id=d12057e4136 href="http://www.ncbi.nlm.nih.gov/pubmed/23396942">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4140 href="https://doi.org/10.4049/jimmunol.1202725">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d12057e4149 class=n-a></a>Acuto O, Michel F: CD28-mediated co-stimulation: a quantitative support for TCR signalling. <i>Nat Rev Immunol.</i> 2003; <b>3</b>(12): 939–51. <a target=xrefwindow id=d12057e4157 href="http://www.ncbi.nlm.nih.gov/pubmed/14647476">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4160 href="https://doi.org/10.1038/nri1248">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d12057e4170 class=n-a></a>Scotet E, Peyrat MA, Saulquin X, <i> et al.</i>: Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. <i>Eur J Immunol.</i> 1999; <b>29</b>(3): 973–85. <a target=xrefwindow id=d12057e4181 href="http://www.ncbi.nlm.nih.gov/pubmed/10092102">PubMed Abstract </a> | <a target="xrefwindow" id="d12057e4184" href="https://doi.org/10.1002/(SICI)1521-4141(199903)29:03<973::AID-IMMU973&gt;3.0.CO;2-P">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d12057e4193 class=n-a></a>Rozenblyum EV, Allen UD, Silverman ED, <i> et al.</i>: Cytomegalovirus infection in childhood-onset systemic lupus erythematosus. <i>Int J Clin Rheumtol.</i> 2013; <b>8</b>(1): 137–46. <a target=xrefwindow id=d12057e4204 href="http://www.ncbi.nlm.nih.gov/pubmed/24527062">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4207 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3920748">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d12057e4216 class=n-a></a>Haaheim LR, Halse AK, Kvakestad R, <i> et al.</i>: Serum antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences. <i>Scand J Immunol.</i> 1996; <b>43</b>(1): 115–21. <a target=xrefwindow id=d12057e4227 href="http://www.ncbi.nlm.nih.gov/pubmed/8560190">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4230 href="https://doi.org/10.1046/j.1365-3083.1996.d01-2.x">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d12057e4239 class=n-a></a>Mak A, Kow NY: The pathology of T cells in systemic lupus erythematosus. <i>J Immunol Res.</i> 2014; <b>2014</b>: 419029. <a target=xrefwindow id=d12057e4247 href="http://www.ncbi.nlm.nih.gov/pubmed/24864268">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4250 href="https://doi.org/10.1155/2014/419029">Publisher Full Text </a> | <a target=xrefwindow id=d12057e4253 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4017881">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d12057e4262 class=n-a></a>Liossis SN, Ding XZ, Dennis GJ, <i> et al.</i>: Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. <i>J Clin Invest.</i> 1998; <b>101</b>(7): 1448–57. <a target=xrefwindow id=d12057e4273 href="http://www.ncbi.nlm.nih.gov/pubmed/9525988">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4276 href="https://doi.org/10.1172/JCI1457">Publisher Full Text </a> | <a target=xrefwindow id=d12057e4280 href="http://www.ncbi.nlm.nih.gov/pmc/articles/508723">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d12057e4289 class=n-a></a>Kawakami A, Matsuoka N, Tsuboi M, <i> et al.</i>: CD4<sup>+</sup> T cell-mediated cytotoxicity toward thyrocytes: the importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone. <i>Lab Invest.</i> 2000; <b>80</b>(4): 471–84. <a target=xrefwindow id=d12057e4303 href="http://www.ncbi.nlm.nih.gov/pubmed/10780664">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4307 href="https://doi.org/10.1038/labinvest.3780053">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d12057e4317 class=n-a></a>Vrbikova J, Janatkova I, Zamrazil V, <i> et al.</i>: Epstein-Barr virus serology in patients with autoimmune thyroiditis. <i>Exp Clin Endocrinol Diabetes.</i> 1996; <b>104</b>(1): 89–92. <a target=xrefwindow id=d12057e4328 href="http://www.ncbi.nlm.nih.gov/pubmed/8750577">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4331 href="https://doi.org/10.1055/s-0029-1211428">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726141758"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12057e4340 class=n-a></a>Ghiti Moghadam M, Vonkeman HE, Ten Klooster PM, <i> et al.</i>: Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(8): 1810–7. <a target=xrefwindow id=d12057e4351 href="http://www.ncbi.nlm.nih.gov/pubmed/26866428">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4354 href="https://doi.org/10.1002/art.39626">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726141758">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d12057e4367 class=n-a></a>Akbar AN, Henson SM: Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? <i>Nat Rev Immunol.</i> 2011; <b>11</b>(4): 289–95. <a target=xrefwindow id=d12057e4375 href="http://www.ncbi.nlm.nih.gov/pubmed/21436838">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4378 href="https://doi.org/10.1038/nri2959">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d12057e4387 class=n-a></a>Link A, Selejan S, Hewera L, <i> et al.</i>: Rosuvastatin induces apoptosis in CD4<sup>+</sup>CD28<sup>null</sup> T cells in patients with acute coronary syndromes. <i>Clin Res Cardiol.</i> 2011; <b>100</b>(2): 147–58. <a target=xrefwindow id=d12057e4405 href="http://www.ncbi.nlm.nih.gov/pubmed/20852871">PubMed Abstract </a> | <a target=xrefwindow id=d12057e4408 href="https://doi.org/10.1007/s00392-010-0225-8">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Mar 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-327/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-327/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Clinical and Experimental medicine, Brighton and Sussex Medical School, Brighton, Sussex, BN1 9PX, UK<br/> <sup>2</sup> Department of Immunology, Maimonides Institute for Biomedical Research (IMIBIC), Reina Sofia Hospital, University of Cordoba, Av. Menendez Pidal, 14004, Cordoba, Spain<br/> <p> <div class=margin-bottom> Aalia Bano <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Alejandra Pera <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Ahmad Almoukayed <br/> <span>Roles: </span> Software </div> <div class=margin-bottom> Thomas H.S. Clarke <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Sukaina Kirmani <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Kevin A. Davies <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Florian Kern <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-327/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 25 Mar 2019, 8:327 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.17119.1">https://doi.org/10.12688/f1000research.17119.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Bano A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=18717 data-id=17119 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17119.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-327/v1/pdf?article_uuid=65ba3326-bf68-4786-8c48-63ba1b26f3f5" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.17119.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Bano A, Pera A, Almoukayed A <em>et al.</em> CD28<sup>null</sup> CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):327 (<a href="https://doi.org/10.12688/f1000research.17119.1" target=_blank>https://doi.org/10.12688/f1000research.17119.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=17119 id=mobile-track-article-signin-17119 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17119?target=/articles/8-327/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18717 /> <input name=articleId type=hidden value=17119 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Thomas Kamradt</strong>, Institute of Immunology, University Hospital Jena, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Janko Nikolich-&#381;ugich</strong>, Department of Immunobiology, University of Arizona College of Medicine-Tucson, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Mar 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-327/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-327/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=48042-46005></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=48043-46006></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-327/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>25 Mar 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Thomas Kamradt</strong>, Institute of Immunology, University Hospital Jena, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Janko Nikolich-&#381;ugich</strong>, Department of Immunobiology, University of Arizona College of Medicine-Tucson, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-327/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-327/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "CD28null CD4 T-cell expansions in autoimmune...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-327/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-327/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-327/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Bano A et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-327/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-327",
            templates : {
                twitter : "CD28null CD4 T-cell expansions in autoimmune disease suggest.... Bano A et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-327/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/17119/18717")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "18717");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "46005": 0,
                           "46006": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b222bc48-c8a7-4a63-8182-c0fa51f6d300";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-327.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-327.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-327.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-327.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-327.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>